Alzheimer disease

G6_ALZHEIMER

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G30 Hospital discharge: ICD-9 — 3310 Cause of death: ICD-10 — G30 Cause of death: ICD-9 — 3310 2 out of 7 registries used, show all original rules.	17144
4. Check minimum number of events None	17144
5. Include endpoints None	17144
6. Filter based on genotype QC (FinnGen only)	16652

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G30-G32
Name in latin: Morbus Alzheimer

NAME	G6_ALZHEIMER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G30
HD_ICD_9	3310
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G30
COD_ICD_9	3310
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	227475	144794	80971
Only index persons	189864	122913	66951
Unadjusted period prevalence (%)
Whole population	3.46	4.15	2.26
Only index persons	3.83	4.52	2.56
Median age at first event (years)
Whole population	82.31	83.07	81.01
Only index persons	82.76	83.50	81.40

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16652	8008	8644
Unadjusted period prevalence (%)	3.42	2.84	3.96
Median age at first event (years)	80.83	80.85	80.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15499: Matched controls
113387

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

101.6

318.4

219

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

309.8

3772

14757

N05BA04

ATC

oxazepam; oral

2.2

307.7

4872

19201

N06DA04

ATC

galantamine; oral

16.0

307.7

2135

1124

WYA20

NOMESCO Finland

Home visit

6.5

307.7

818

964

G30.0

ICD-10 Finland

Alzheimer disease with early onset

461.6

307.7

1167

N06DA02

ATC

donepezil; oral

37.6

307.7

7263

2596

F0019, G301,

ICD-10 Finland

5550.4

307.7

731

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

27.6

307.7

2463

770

G30

ICD-10 Finland

Alzheimer disease

57.1

307.7

1263

176

SPAT1234

SPAT

Support of social functional capacity

3.1

307.7

1713

4313

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.3

307.7

4634

7185

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.9

307.7

1824

3776

N06DA03

ATC

rivastigmine; oral, transdermal

23.7

307.7

4597

1978

SPAT1053

SPAT

Memory test

3.6

307.7

5974

16825

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

307.7

6552

30299

N05AX08

ATC

risperidone; systemic

10.0

307.7

4580

4586

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

4926

19642

G30.1

ICD-10 Finland

Alzheimer disease with late onset

117.0

307.7

9239

1412

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

78.0

307.7

5389

770

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

168.1

307.7

723

G30.8

ICD-10 Finland

Other Alzheimer disease

74.1

307.7

2974

362

P20

ICPC

Memory disturbance

7.1

307.7

7644

13689

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

223.5

307.7

5193

255

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

48.6

307.7

4096

832

N06DX01

ATC

memantine; oral

56.9

307.7

9678

3218

F05.1

ICD-10 Finland

Delirium superimposed on dementia

12.8

307.7

499

295

F009, G309,

ICD-10 Finland

1607.9

307.7

442

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

34.9

307.7

764

168

P70

ICPC

Dementia

15.9

307.7

2036

1066

SPAT1216

SPAT

Assessment of functional ability

2.3

307.7

4180

15906

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

38.4

307.7

537

106

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

307.7

2173

6370

F06.7

ICD-10 Finland

Mild cognitive disorder

4.5

307.7

1287

2240

A28

ICPC

Limited function/disability NOS

2.8

307.7

5770

19618

R41.3

ICD-10 Finland

Other amnesia

5.5

307.7

1294

1864

F03

ICD-10 Finland

Unspecified dementia

6.5

307.7

2940

3940

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

45.1

307.7

1311

232

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

307.7

2886

8278

N05AH04

ATC

quetiapine; oral

4.1

307.7

3559

7666

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

303.6

1152

2453

TAB00

NOMESCO Finland

Lumbar puncture

4.6

297.2

813

1346

N03AG01

ATC

valproic acid; systemic, rectal

3.6

270.8

1043

2240

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

267.7

4596

20217

N06AX11

ATC

mirtazapine; oral

1.9

260.8

5283

24505

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

54.1

256.2

190

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

239.1

3614

15117

N05AH03

ATC

olanzapine; systemic

3.7

236.0

847

1728

SPAT1254

SPAT

Administration of medicine

2.0

234.8

3313

13513

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

234.1

1384

3850

AA1AD

NOMESCO Finland

CT of head and brain

1.8

230.1

5557

26969

F001, G301,

ICD-10 Finland

83.9

226.9

159

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

220.0

5856

29141

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

70.6

214.1

153

F0009, G300,

ICD-10 Finland

+∞

213.2

231

N02AA05

ATC

oxycodone; systemic

1.8

204.8

3906

17514

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4.6

200.9

542

884

N06AB10

ATC

escitalopram; oral

2.1

199.5

2203

8146

N06AX26

ATC

vortioxetine; oral

3.2

198.3

878

2058

N05AD01

ATC

haloperidol; systemic

3.2

188.2

859

2051

XA800

NOMESCO Finland

Neuropsychological investigation

4.1

186.3

587

1085

A04

ICPC

Weakness/tiredness general

1.9

182.3

2829

11804

F00

ICD-10 Finland

Dementia in Alzheimer disease

14.4

179.8

197

101

A06AD11

ATC

lactulose; oral

1.8

179.3

3646

16566

Z75.5

ICD-10 Finland

Holiday relief care

5.2

173.1

404

578

L28

ICPC

Limited function/disability (L)

1.7

168.4

3889

18288

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

160.5

1126

3398

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

34.2

160.3

130

S72.0

ICD-10 Finland

Fracture of neck of femur

2.4

158.1

1282

4140

F0029, G308,

ICD-10 Finland

+∞

157.7

171

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

148.4

2455

28786

U04

ICPC

Incontinence urine

2.3

148.2

1300

4343

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.0

147.5

1887

7317

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

146.9

2885

12871

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.1

141.6

442

810

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.7

140.3

861

2425

N02BE01

ATC

paracetamol; systemic, rectal

1.8

137.4

12962

84377

F0014, G301,

ICD-10 Finland

228.9

135.1

156

SPAT1101

SPAT

Orthostatic test

2.3

135.1

1196

4006

S01.0

ICD-10 Finland

Open wound of scalp

2.1

130.7

1534

5749

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

130.0

1077

3502

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.7

125.9

453

922

SPAT1301

SPAT

No procedures

1.5

118.4

5220

28301

R55

ICD-10 Finland

Syncope and collapse

1.8

116.0

2312

10287

SPAT1252

SPAT

Overall medication plan or its review

2.0

113.9

1475

5715

I95.1

ICD-10 Finland

Orthostatic hypotension

2.2

112.3

1049

3586

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

111.7

2920

13974

SPAT1360

SPAT

Extensive global examination

2.0

110.9

1355

5140

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

110.3

2256

10100

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

110.2

604

1598

F21, ,

ICPC

4.3

107.6

316

552

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

33.3

105.3

130

Kela drug reimbursment

Malignant tumour

0.3

105.2

377

7994

S06.0

ICD-10 Finland

Concussion

1.9

102.8

1632

6759

AXX01, ,

SPAT

2.5

99.5

708

2141

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

95.6

785

11738

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

31.9

94.5

N06AB04

ATC

citalopram; systemic

1.6

92.6

2863

14196

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

92.6

1896

8457

SPAT1229

SPAT

Assessment of need for aid

1.8

89.0

1658

7194

S70.0

ICD-10 Finland

Contusion of hip

2.2

86.8

821

2814

W19

ICD-10 Finland

Unspecified fall

1.8

86.4

1650

7206

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.6

85.2

564

1646

A29

ICPC

General symptom/complaint other

1.6

83.4

2121

10004

H02AB02

ATC

dexamethasone; systemic

0.4

80.1

428

7604

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

78.9

1649

7378

Z29

ICPC

Social problem NOS

3.1

78.5

365

878

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

35.6

78.3

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

77.4

E86

ICD-10 Finland

Volume depletion

2.4

76.8

604

1911

AXX01

NOMESCO Finland

Memory assessment

11.0

76.1

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.1

75.3

228

408

N06AB06

ATC

sertraline; oral

1.9

75.0

1051

4162

N05AD03

ATC

melperone; systemic

3.2

74.8

333

780

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

72.8

2825

28201

F002, G308,

ICD-10 Finland

29.9

72.6

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

4.9

71.9

178

269

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

71.3

1084

4407

SPAT1172

SPAT

Guidance concerning hydration

2.3

71.0

623

2067

SPAT1139

SPAT

Nutrition survey

2.2

70.6

630

2106

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

67.9

2061

21673

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

67.6

2127

10512

SPAT1251

SPAT

Organisation of medication

2.1

67.5

729

2629

N30.0

ICD-10 Finland

Acute cystitis

1.5

66.6

2443

12482

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

9.4

66.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

66.4

3916

21915

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

65.7

851

3278

F0011, G301,

ICD-10 Finland

116.2

65.5

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.3

65.5

278

632

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

64.8

1300

5736

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

64.4

1056

4391

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

63.9

532

1725

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

13.5

62.1

N07AA05, ,

ATC

132.3

60.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

60.3

987

4100

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

30.6

59.9

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

58.5

1771

8656

OAB76

NOMESCO Finland

General guidance on nutrition and food

12.6

57.3

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

57.2

1571

16962

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

56.7

639

2340

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

56.6

597

2133

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.2

56.0

246

572

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

25.7

55.9

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

53.5

305

824

C10AA01

ATC

simvastatin; oral

1.3

53.1

7947

50664

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

51.6

2736

14928

A10AB05

ATC

insulin aspart; parenteral

1.7

51.4

1114

5009

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

25.4

51.1

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

51.1

728

2892

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

51.0

1172

5349

F0024, G308,

ICD-10 Finland

+∞

50.6

W0A10

NOMESCO Finland

Mapping of psychosocial situation

9.0

49.4

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.3

49.4

421

1379

WZC30

NOMESCO Finland

Teaching

0.6

49.4

878

10534

J01CA08

ATC

pivmecillinam; oral

1.3

49.0

4989

30088

WX402

NOMESCO Finland

General anaesthesia

0.6

48.8

977

11382

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

24.3

48.2

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

48.1

1384

14860

EB1VA, ,

NOMESCO Finland

0.4

47.8

308

5109

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.2

47.1

440

1498

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

85.2

46.8

R33

ICD-10 Finland

Retention of urine

1.5

46.7

1675

8466

A04AA02

ATC

granisetron; systemic, transdermal

0.3

46.0

168

3575

G04CA02

ATC

tamsulosin; oral

1.3

45.7

4649

27970

SPAT1167

SPAT

Insertion of urinary catheter

1.8

45.6

718

2943

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

45.5

1787

18084

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

45.3

1361

6618

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

45.2

2115

11255

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

17.4

44.7

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

44.6

708

2909

G04CB01

ATC

finasteride; oral

1.4

43.7

2515

13873

-2, ,

ICPC

3.6

43.0

153

310

SPAT1153

SPAT

Removal of sutures

0.7

42.7

3021

27829

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

42.6

1150

12547

Z28

ICPC

Limited function/disability (Z)

4.0

42.6

134

248

F0012, G301,

ICD-10 Finland

351.2

42.5

ICB01, ,

SPAT

5.3

42.5

131

F22.0

ICD-10 Finland

Delusional disorder

2.8

41.9

223

581

SPAT1050

SPAT

Extensive neurological examination

2.2

41.8

362

1194

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

41.5

400

1379

LAITO, ,

NOMESCO Finland

9.5

41.2

J01EA01

ATC

trimethoprim; systemic

1.3

41.0

3903

23196

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

41.0

2450

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.3

39.3

311

987

J01DB01

ATC

cefalexin; oral

1.3

39.2

10616

71485

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

39.1

469

1757

G31.0

ICD-10 Finland

Circumscribed brain atrophy

4.0

39.0

123

228

C10AX09

ATC

ezetimibe; oral

0.6

38.9

1010

11129

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

18.6

38.8

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

38.7

2418

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

11.0

38.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

37.6

4218

25555

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.4

37.4

273

835

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

36.9

399

1439

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

36.6

2383

13367

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.4

36.6

269

826

P05

ICPC

Senility, feeling/behaving old

3.3

36.6

152

342

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

36.6

480

1855

Z2445

NOMESCO Finland

Psychologist

2.4

35.8

255

772

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.2

35.5

114

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

35.3

1266

6381

C10AA07

ATC

rosuvastatin; oral

0.8

35.2

2566

23668

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

35.0

5359

33634

R5110, ,

SPAT

1.5

34.9

1042

5051

AA1AD, ,

SPAT

5.5

34.5

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.7

34.5

681

2980

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.1

34.3

154

364

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

34.3

2769

25203

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

34.2

377

1369

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

34.2

628

7510

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

34.0

4169

25470

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

33.8

956

4579

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

3.9

33.7

108

203

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

33.3

1415

7370

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

33.2

722

3241

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

33.2

1258

6409

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

61.6

32.7

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

32.7

206

588

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

32.5

196

3346

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

32.5

409

1558

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

32.5

1351

13625

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

32.5

981

4767

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.9

31.9

104

198

F05.8

ICD-10 Finland

Other delirium

2.9

31.8

164

421

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

31.7

391

1479

F0021, G308,

ICD-10 Finland

262.6

31.6

F0022, G308,

ICD-10 Finland

+∞

31.3

F0013, G301,

ICD-10 Finland

+∞

31.3

JN4AD

NOMESCO Finland

Body CT examination

0.6

30.8

696

7933

A04AA01

ATC

ondansetron; systemic, rectal

0.5

30.7

350

4780

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

30.5

2196

12476

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

30.4

1361

7156

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

30.2

2207

12567

SPAT1263

SPAT

Sampling

1.2

30.1

5481

34895

M01AH05

ATC

etoricoxib; oral

0.8

29.9

4775

40264

N02AX02

ATC

tramadol; systemic, rectal

0.8

29.8

4506

38214

S18

ICPC

Laceration/cut

0.8

29.6

4783

40296

SPAT1284

SPAT

Extensive health certificate

2.1

29.5

305

1082

A10AE04

ATC

insulin glargine; parenteral

1.4

29.4

1313

6897

WYA20, ,

SPAT

3.5

29.3

108

225

F009, F03,

ICD-10 Finland

10.3

29.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

28.9

1581

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

28.8

4726

29719

EB4VA, ,

NOMESCO Finland

0.4

28.4

149

2693

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

85.5

28.4

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

28.4

1501

8120

N28

ICPC

Limited function/disability (N)

2.2

28.3

264

900

Z51.5

ICD-10 Finland

Palliative care

1.4

28.1

1443

7765

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

28.1

433

1764

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

28.0

125

2420

A10BK03

ATC

empagliflozin; oral

0.6

27.7

513

6134

N27

ICPC

Fear of neurological disease other

2.1

27.6

273

953

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

27.5

1629

8976

L01BC06

ATC

capecitabine; oral

0.4

27.1

113

2257

C03DA01

ATC

spironolactone; oral

0.7

26.9

1296

12783

F00, F03,

ICD-10 Finland

6.9

26.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

26.7

903

4491

P29

ICPC

Psychological sympt/compl other

1.9

26.6

355

1380

SPAT1262

SPAT

Handing over of treatment supplies

1.3

26.6

2507

14755

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

26.6

126

2377

L15

ICPC

Knee symptom/complaint

0.8

26.6

1785

16750

SDA03

NOMESCO Finland

Periodontal treatment

0.8

26.3

2277

20662

Y94.1

ICD-10 Finland

Accident in connection with service housing

7.5

26.3

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.5

26.2

203

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

26.0

633

7105

W06

ICD-10 Finland

Fall involving bed

2.5

26.0

180

539

E0000UV, ,

ATC

1.2

26.0

4956

31572

F0024, G301,

ICD-10 Finland

+∞

25.8

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.2

25.5

220

727

E000001, ,

ATC

1.3

25.2

2257

13184

H02AB06

ATC

prednisolone; systemic

0.8

25.2

5202

43011

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

25.1

1608

8961

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

25.1

946

9735

HA1RA, ,

SPAT

0.2

24.9

1367

Z03

ICPC

Housing/neighbourhood problem

3.1

24.7

112

267

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

24.5

327

1272

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

4.0

24.4

137

N17

ICPC

Vertigo/dizziness

1.3

24.3

1801

10251

J01MA02

ATC

ciprofloxacin; systemic

1.2

24.2

5674

36799

Z51.88

ICD-10 Finland

Other specified medical care

2.0

24.1

293

1104

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.7

24.1

1413

13541

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

24.0

302

1153

F009, G301,

ICD-10 Finland

+∞

23.9

SPAT1014

SPAT

Treatment of eyes

1.9

23.8

309

1192

R06.0

ICD-10 Finland

Dyspnoea

0.8

23.7

2959

25770

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

23.4

2968

25818

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.9

23.3

315

1232

C03CA01

ATC

furosemide; systemic

1.2

23.3

6742

44518

TQW40, ,

SPAT

0.5

23.1

284

3793

P04

ICPC

Feeling/behaving irritable/angry

4.9

23.0

N07AA06, ,

ATC

+∞

23.0

F0004, G300,

ICD-10 Finland

+∞

23.0

N29

ICPC

Neurological sympt/complt other

2.0

23.0

270

1006

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

22.9

368

1520

D12

ICPC

Constipation

1.6

22.9

559

2586

T03

ICPC

Loss of appetite

3.8

22.7

148

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

22.2

626

6815

R03AC02

ATC

salbutamol; inhalant

0.8

22.1

5093

41862

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

5.6

22.1

L08

ICPC

Shoulder symptom/complaint

0.8

22.1

1599

14893

R11

ICD-10 Finland

Nausea and vomiting

1.4

22.0

1115

5980

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

29.3

22.0

P28

ICPC

Limited function/disability (P)

3.3

22.0

198

Y94.0

ICD-10 Finland

Accident at home

1.9

21.9

291

1131

U13

ICPC

Bladder symptom/complaint other

1.7

21.9

417

1808

XF606, ,

SPAT

2.9

21.8

112

288

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

21.7

1695

9710

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.7

21.6

390

1666

R1250, ,

SPAT

2.1

21.4

226

811

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.5

21.3

707

3503

Z60.8

ICD-10 Finland

Other problems related to social environment

3.7

21.3

145

S28

ICPC

Limited function/disability (S)

2.6

21.3

127

354

R01AD58

ATC

fluticasone, combinations; nasal

0.7

21.2

871

8844

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

21.2

1044

10287

A78

ICPC

Infectious disease other/NOS

2.4

21.0

146

439

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

21.0

400

4750

C04AE01

ATC

ergoloid mesylates; systemic

2.3

20.8

159

499

F0023, G308,

ICD-10 Finland

175.8

20.7

L75

ICPC

Fracture: femur

1.9

20.7

258

983

ZXY02

NOMESCO Finland

Neuropsychologist

4.9

20.6

IHZ08, ,

SPAT

4.9

20.6

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

6.2

20.4

H02AA02

ATC

fludrocortisone; oral

2.3

20.4

159

504

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

20.2

2037

18221

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

20.1

4165

26588

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

20.0

114

1987

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

19.9

241

908

A10BK01

ATC

dapagliflozin; oral

0.6

19.9

348

4223

WF002

NOMESCO Finland

Radical radiotherapy

0.6

19.9

299

3773

S82

ICPC

Naevus/mole

0.7

19.9

800

8155

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

19.9

558

I67.4

ICD-10 Finland

Hypertensive encephalopathy

6.6

19.8

N03AX14

ATC

levetiracetam; systemic

1.8

19.8

315

1297

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

19.8

551

6021

G72.8

ICD-10 Finland

Other specified myopathies

1.9

19.6

262

1021

R54

ICD-10 Finland

Senility

2.5

19.4

134

402

G47.3

ICD-10 Finland

Sleep apnoea

0.8

19.1

1271

11991

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.2

19.0

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

4.2

19.0

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

4.7

18.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

18.8

5953

39354

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

18.8

398

1778

Z01.2

ICD-10 Finland

Dental examination

0.8

18.8

3030

25825

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

18.7

199

717

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.9

18.6

261

1034

M04AA01

ATC

allopurinol; systemic

0.8

18.5

1641

14926

M70.6

ICD-10 Finland

Trochanteric bursitis

0.7

18.5

989

9632

A10AE05

ATC

insulin detemir; parenteral

1.5

18.5

630

3139

K59.0

ICD-10 Finland

Constipation

1.4

18.4

879

4665

R45.5

ICD-10 Finland

Hostility

9.6

18.3

T05

ICPC

Feeding problem of adult

3.0

18.2

211

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

18.2

862

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

18.1

946

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.7

18.1

327

1400

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

2.6

18.0

110

311

G04BD08

ATC

solifenacin; oral

1.4

18.0

1040

5695

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

43.9

18.0

WW500

NOMESCO Finland

Blood transfusion

0.5

17.9

200

2747

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

80.6

17.9

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

17.9

135

2110

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

17.7

557

2729

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.8

17.5

240

WYA30, ,

SPAT

3.0

17.4

209

XQ858, ,

SPAT

3.3

17.4

152

SPAT1058

SPAT

PEF monitoring instruction

0.7

17.4

498

5409

L03AA13

ATC

pegfilgrastim; parenteral

0.5

17.3

127

2004

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

17.2

390

4450

A27

ICPC

Fear of other disease NOS

1.5

17.2

628

3174

D82

ICPC

Teeth/gum disease

0.8

17.1

2089

18339

N05CD07

ATC

temazepam; oral

1.2

17.0

2078

12559

XF606

NOMESCO Finland

Ortostatic test

2.3

16.9

128

401

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

16.9

1655

9746

K08.3

ICD-10 Finland

Retained dental root

1.4

16.9

868

4665

SPAT1125

SPAT

Stoma care and guidance

1.7

16.7

312

1348

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

16.7

1076

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

16.6

281

3437

XQ855, ,

SPAT

2.4

16.6

115

346

F0019, G309,

ICD-10 Finland

+∞

16.6

N05AH02

ATC

clozapine; systemic

3.1

16.5

180

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

16.5

2112

12823

R4110, ,

SPAT

0.7

16.4

486

5246

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

16.4

1557

S01

ICD-10 Finland

Open wound of head

2.1

16.4

167

593

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.7

16.3

254

N99

ICPC

Neurological disease other

2.2

16.3

151

516

R74

ICPC

Upper respiratory infection acute

0.8

16.3

1279

11821

L03

ICPC

Low back symptom/complaint

0.8

16.3

2101

18347

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

16.2

987

5449

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.4

16.2

130

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.5

16.2

613

3120

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

5.3

16.1

ZXA00

NOMESCO Finland

Right side

1.2

16.1

3868

24927

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

16.0

2886

24416

W0A10, ,

SPAT

8.0

16.0

Z75.0

ICD-10 Finland

Medical services not available in home

3.4

16.0

131

D19

ICPC

Teeth/gum symptom/complaint

0.8

15.9

1517

13697

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

15.9

1952

11794

KMAK, ,

NOMESCO Finland

1.2

15.9

4603

30107

A10BB12

ATC

glimepiride; oral

1.3

15.9

1303

7503

C09CA06

ATC

candesartan; oral

0.8

15.8

1956

17163

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.9

15.8

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

15.8

1597

14322

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

15.8

1459

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

15.8

211

825

H04AA01

ATC

glucagon; nasal, parenteral

2.4

15.7

117

365

JN4BD

NOMESCO Finland

Extensive body CT

0.7

15.6

896

8639

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

15.6

1204

11151

N02BF01

ATC

gabapentin; oral

0.7

15.5

409

4519

F32

ICD-10 Finland

Depressive episode

1.7

15.5

320

1422

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.8

15.4

224

S01.8

ICD-10 Finland

Open wound of other parts of head

1.9

15.3

189

720

A04AA55

ATC

palonosetron, combinations; systemic

0.3

15.3

954

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.6

15.2

348

1586

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

15.2

222

893

A01

ICPC

Pain general/multiple sites

1.3

15.2

1117

6338

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

15.1

277

3317

R45.1

ICD-10 Finland

Restlessness and agitation

4.1

15.0

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

3.0

15.0

179

A10BJ06

ATC

semaglutide; parenteral

0.4

15.0

1531

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

15.0

1079

10089

L57.0

ICD-10 Finland

Actinic keratosis

0.8

15.0

1317

12010

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

15.0

1300

11873

N05AX12

ATC

aripiprazole; systemic

2.3

15.0

122

396

WX199

NOMESCO Finland

Other local analgesia

0.5

14.9

179

2402

WZC30, ,

SPAT

0.6

14.8

247

3027

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.5

14.8

538

2719

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

14.7

517

2593

F000, G300,

ICD-10 Finland

+∞

14.7

F0001, G300,

ICD-10 Finland

+∞

14.7

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

14.7

115

1772

E66.01

ICD-10 Finland

Obesity due to excess calories

0.5

14.7

181

2409

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

14.7

135

461

R44.1

ICD-10 Finland

Visual hallucinations

2.4

14.6

101

304

R01AD12

ATC

fluticasone furoate; nasal

0.8

14.6

1505

13481

U28

ICPC

Limited function/disability (U)

1.9

14.6

180

685

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.6

14.5

371

4123

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

14.5

977

5474

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

14.4

237

2919

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.9

14.4

179

683

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

14.4

338

3826

115

Kela drug reimbursment

Breast cancer

0.7

14.4

476

5028

HA1AA

NOMESCO Finland

X-ray mammography

0.7

14.4

384

4229

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.2

14.3

120

394

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

14.3

619

3231

GD1AA, ,

SPAT

0.6

14.3

212

2680

Z74.1

ICD-10 Finland

Need for assistance with personal care

8.1

14.2

L90

ICPC

Osteoarthrosis of knee

0.7

14.2

464

4914

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.6

14.2

198

2546

ZX120

NOMESCO Finland

Intravenous

0.7

14.2

679

6735

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

14.2

851

4687

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

14.2

131

1905

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

14.1

641

3373

D07AA02

ATC

hydrocortisone; topical

1.3

14.1

1360

7989

R03BA08

ATC

ciclesonide; inhalant

0.7

14.1

396

4315

L13

ICPC

Hip symptom/complaint

0.8

14.0

1712

15060

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.8

13.9

1393

12519

G04BD07

ATC

tolterodine; oral

1.4

13.9

816

4481

M25.5

ICD-10 Finland

Pain in joint

0.8

13.8

2123

18262

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

13.8

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

13.8

164

SPAT1042

SPAT

Guidance concerning balance maintenance

2.4

13.7

291

ZXD35

NOMESCO Finland

Usual procedure

1.5

13.7

397

1913

A69.2

ICD-10 Finland

Lyme disease

0.6

13.7

247

2972

SPAT1111

SPAT

Planning of analgesia

2.0

13.7

157

583

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

13.6

1463

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.2

13.5

113

371

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

13.5

832

S22.3

ICD-10 Finland

Fracture of rib

1.3

13.5

832

4602

S01BC05

ATC

ketorolac; ophthalmic

1.4

13.5

712

3845

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

13.4

121

1774

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

13.4

186

737

B01AB10

ATC

tinzaparin; parenteral

0.7

13.4

652

6450

SPAT1285

SPAT

Provision of consultation response

1.4

13.4

634

3363

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

13.4

606

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

13.3

398

1932

WW200, ,

SPAT

0.8

13.3

1609

14174

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

13.3

439

4636

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.3

13.2

118

R2110

NOMESCO Finland

Giving the first information

1.4

13.2

566

2949

ZX120, ,

SPAT

2.1

13.2

122

418

R40.2

ICD-10 Finland

Coma, unspecified

2.1

13.1

133

472

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

13.1

297

3388

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

13.1

1349

7983

L03AA02

ATC

filgrastim; parenteral

0.5

13.1

1482

A05

ICPC

Feeling ill

1.5

13.0

446

2227

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

13.0

678

3654

A10BH05

ATC

linagliptin; oral

1.3

13.0

837

4661

S15

ICPC

Foreign body in skin

0.7

13.0

369

4010

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

12.9

837

7940

Z11

ICPC

Compliance/being ill problem

2.4

12.9

291

HA1AA, ,

SPAT

0.2

12.8

723

N05AB03

ATC

perphenazine; systemic, rectal

1.6

12.8

291

1328

AA1CG, ,

SPAT

2.4

12.7

279

K86

ICPC

Hypertension uncomplicated

0.8

12.7

1292

11600

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

12.6

1111

I95.9

ICD-10 Finland

Hypotension, unspecified

1.7

12.6

233

1006

G04CB02

ATC

dutasteride; oral

1.3

12.6

1290

7629

L02BG04

ATC

letrozole; oral

0.6

12.6

317

3532

TDA90, ,

SPAT

0.6

12.4

310

3462

N06AX16

ATC

venlafaxine; oral

1.3

12.4

900

5098

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

12.2

1084

WX290

NOMESCO Finland

Other blockage of nerve

0.8

12.2

2446

20576

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

12.2

150

1995

F06.0

ICD-10 Finland

Organic hallucinosis

3.3

12.2

106

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

4.6

12.2

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

12.1

101

1519

N06AX21

ATC

duloxetine; oral

1.3

12.1

967

5546

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.4

12.1

948

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.5

12.0

103

1534

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

12.0

1973

16884

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

12.0

327

3583

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

12.0

646

3501

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

12.0

4303

34661

XA400

NOMESCO Finland

EEG

2.6

12.0

212

T93

ICPC

Lipid disorder

0.7

12.0

388

4111

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

11.9

367

3923

T08

ICPC

Weight loss

1.7

11.8

199

838

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.5

11.8

ZXA05

NOMESCO Finland

Left side

1.2

11.8

3584

23424

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

11.8

1483

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

11.8

411

2063

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

0.9

11.7

3337

27332

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

11.7

579

5713

SFA20

NOMESCO Finland

Two-surface restoration

0.9

11.7

4172

33637

K05.30

ICD-10 Finland

Periodontitis complex

0.8

11.7

909

8424

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.2

11.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.6

11.7

257

1164

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

11.5

749

4175

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.4

11.5

238

T82

ICPC

Obesity

0.3

11.5

828

WX111

NOMESCO Finland

Local infiltration anesthesia

0.6

11.5

175

2194

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.7

11.5

306

3369

I50.1

ICD-10 Finland

Left ventricular failure

0.7

11.5

564

5571

UJF30

NOMESCO Finland

Ileoscopy through colon

0.7

11.5

631

6128

L89

ICPC

Osteoarthrosis of hip

0.6

11.4

215

2553

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

11.4

173

2169

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

11.4

197

837

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

0.6

11.3

215

2551

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.3

3525

23068

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.1

11.3

5710

38583

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.5

11.3

133

1790

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

11.3

1841

11427

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

11.3

1453

8811

OAB43, ,

SPAT

0.4

11.3

1170

S06.3

ICD-10 Finland

Focal brain injury

1.8

11.3

165

667

P18

ICPC

Medication abuse

3.1

11.2

112

250, ,

Kela drug reimbursment

0.3

11.2

838

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.6

11.2

270

3033

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

11.2

519

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.8

11.2

676

6475

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

11.1

1094

6438

N07

ICPC

Convulsion/seizure

4.3

11.1

SPAT1138

SPAT

Guidance concerning bowel function

1.7

11.1

216

949

F0021, G301,

ICD-10 Finland

36.6

11.0

F0009, G309,

ICD-10 Finland

+∞

11.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

11.0

5989

40628

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

0.8

11.0

1705

14682

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.1

11.0

101

346

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

11.0

1161

6890

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

11.0

376

1880

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.3

11.0

694

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

11.0

189

2294

S32.5

ICD-10 Finland

Fracture of pubis

1.8

11.0

156

625

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.7

11.0

459

4649

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.7

11.0

210

918

AA1AA

NOMESCO Finland

Head X-ray examination

2.1

10.9

110

391

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

10.9

1020

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

2.7

10.9

162

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.9

1733

10733

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.8

10.8

679

6472

D06BB10

ATC

imiquimod; topical

0.7

10.8

340

3622

M76.6

ICD-10 Finland

Achilles tendinitis

0.6

10.8

158

2000

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.9

10.8

4302

34478

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

10.8

556

5451

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.4

10.8

542

2906

A23

ICPC

Risk factor NOS

1.4

10.8

569

3076

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

10.7

1407

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.9

10.7

2420

20190

S21

ICPC

Skin texture symptom/complaint

0.8

10.7

1194

10621

L01

ICPC

Neck symptom/complaint

0.8

10.7

958

8732

XCH00

NOMESCO Finland

Eye pressure measurement

0.7

10.7

346

3668

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

10.7

500

4976

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

10.7

271

3013

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

10.7

1075

9667

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

10.7

227

1020

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

10.7

524

5174

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.8

10.6

852

7868

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

10.6

142

1842

R01AD59

ATC

mometasone, combinations; nasal

0.3

10.6

727

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.8

10.6

154

621

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

1.7

10.6

194

838

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.0

10.6

117

431

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.7

10.5

165

M02AA07

ATC

piroxicam; topical

1.1

10.5

4925

33083

A11CC03

ATC

alfacalcidol; systemic

0.5

10.5

108

1511

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.8

10.4

147

588

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

10.4

555

R31

ICD-10 Finland

Unspecified haematuria

1.2

10.4

1641

10153

SPAT1104

SPAT

Monitoring of emergency patient

1.3

10.3

822

4713

C10AA02

ATC

lovastatin; oral

1.3

10.3

744

4210

SGA01

NOMESCO Finland

Emergency treatment

0.7

10.3

516

5080

SPAT1260

SPAT

Consultation of another employee

1.2

10.3

2167

13749

A12AA04

ATC

calcium carbonate; oral

0.4

10.3

932

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.5

10.3

104

1464

NG1AA, ,

SPAT

0.5

10.2

1186

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.7

10.2

520

5103

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.6

10.2

177

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.8

10.2

872

7985

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.2

10.1

471

N05CF01

ATC

zopiclone; oral

1.1

10.1

4758

31948

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

10.1

652

SPAT1377

SPAT

Polysomnography

0.5

10.1

1192

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.7

10.1

185

799

J01FA10

ATC

azithromycin; systemic

0.9

10.1

4363

34829

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.3

10.1

650

SPAT1236

SPAT

Informing family of child’s disability

1.6

10.1

232

1064

Z08

ICPC

Social welfare problem

2.0

10.0

109

399

SGC00

NOMESCO Finland

Medication, disinfection of root canals

0.7

10.0

342

3588

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

10.0

477

2535

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

10.0

1177

SFA30

NOMESCO Finland

Three-surface restoration

0.9

10.0

3004

24556

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.5

10.0

F009, G308,

ICD-10 Finland

87.9

10.0

K80

ICPC

Cardiac arrhythmia NOS

0.8

9.9

605

5787

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

9.9

288

3112

TK800

NOMESCO Finland

Hemodialysis

0.4

9.9

1070

HA1AE, ,

SPAT

0.2

9.9

345

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.5

9.8

193

G04CA01

ATC

alfuzosin; oral

1.2

9.8

1788

11202

HMAK, ,

NOMESCO Finland

0.7

9.8

556

5376

G40

ICD-10 Finland

Epilepsy

2.3

9.8

234

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

9.7

168

2036

N18

ICPC

Paralysis/weakness

1.5

9.7

262

1247

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

9.7

877

G03DC02

ATC

norethisterone; oral

0.7

9.7

444

4429

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.7

452

4495

S42.0

ICD-10 Finland

Fracture of clavicle

1.5

9.6

260

1238

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.8

9.6

146

598

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

9.6

831

M03BX02

ATC

tizanidine; oral

0.9

9.6

4956

39177

SPAT1255

SPAT

Intravenous administration of medicine

1.3

9.6

823

4766

P19

ICPC

Drug abuse

3.3

9.6

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

9.6

299

3186

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.9

9.6

123

478

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.6

9.6

225

1038

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.5

9.6

187

R18

ICD-10 Finland

Ascites

0.5

9.5

1166

WX722

NOMESCO Finland

PEEP

0.7

9.5

260

2843

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

9.5

972

W18

ICD-10 Finland

Other fall on same level

2.1

9.5

338

S12

ICPC

Insect bite/sting

0.8

9.4

622

5888

S20.2

ICD-10 Finland

Contusion of thorax

1.4

9.4

522

2844

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.1

9.4

319

128

Kela drug reimbursment

Cancers of female genital organs

0.4

9.4

876

R21

ICPC

Throat symptom/complaint

0.8

9.4

848

7722

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.1

9.4

300

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

9.4

669

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

9.4

821

ZXD20

NOMESCO Finland

Day surgery

1.2

9.3

1326

8124

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

3.8

9.3

N84.0

ICD-10 Finland

Polyp of corpus uteri

0.7

9.2

324

3380

L01CA04

ATC

vinorelbine; systemic

0.2

9.2

465

SPAT1244

SPAT

Occupational therapy

1.8

9.2

130

521

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

9.2

1156

10161

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

9.2

948

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

9.1

249

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.5

9.0

102

1385

H02.3

ICD-10 Finland

Blepharochalasis

0.7

9.0

481

4687

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.3

9.0

677

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

9.0

308

3225

S01EX03, ,

ATC

1.4

9.0

407

2148

NF3AA

NOMESCO Finland

Femur X-ray examination

1.5

9.0

293

1455

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

8.9

315

3282

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.7

8.9

247

2692

A01AB09

ATC

miconazole; local oral

1.2

8.9

1105

6675

T68

ICD-10 Finland

Hypothermia

2.3

8.9

203

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.1

8.9

312

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.2

8.9

294

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.2

8.9

2043

13049

S29

ICPC

Skin symptom/complaint other

0.8

8.9

1734

14649

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.6

8.8

196

892

U29

ICPC

Urinary symptom/complaint other

1.4

8.8

365

1895

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.8

8.8

914

8196

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

8.8

337

1725

A10AD05

ATC

insulin aspart; parenteral

1.5

8.8

315

1593

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

0.8

8.8

612

5750

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.4

8.8

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.5

8.8

309

1557

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.5

8.8

173

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.3

8.7

200

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.9

8.7

1950

16305

NA3BG, ,

SPAT

0.4

8.7

888

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.4

8.7

463

2509

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

0.6

8.6

161

1912

N81.6

ICD-10 Finland

Rectocele

0.7

8.6

394

3931

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

8.6

456

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.7

8.6

302

3149

SGB30

NOMESCO Finland

Other complicated root filling

0.7

8.6

219

2428

L01CB01

ATC

etoposide; systemic

0.1

8.6

256

IHA10, ,

SPAT

2.1

8.6

297

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.6

8.5

149

G91.1

ICD-10 Finland

Obstructive hydrocephalus

2.7

8.5

132

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

8.5

239

2597

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

8.5

1214

7439

L16

ICPC

Ankle symptom/complaint

0.8

8.5

686

6325

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.1

8.5

2982

19630

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

8.4

421

2258

K04.5

ICD-10 Finland

Chronic apical periodontitis

0.9

8.4

1892

15818

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

8.4

578

H01

ICPC

Ear pain/earache

0.8

8.4

548

5194

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

4.2

8.4

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.2

8.4

270

R02

ICPC

Shortness of breath/dyspnoea

0.8

8.4

1253

10833

G04BX04, ,

ATC

1.5

8.4

288

1446

ZXD05

NOMESCO Finland

Urgent procedure

1.1

8.3

3750

25060

R44.0

ICD-10 Finland

Auditory hallucinations

2.5

8.3

164

S42.4

ICD-10 Finland

Fracture of lower end of humerus

1.8

8.3

123

501

WX723

NOMESCO Finland

CPAP therapy

0.5

8.3

1178

F0010, G308,

ICD-10 Finland

+∞

8.3

N43

ICPC

Neurological, Other diagnostic procedure

2.2

8.3

238

R44

ICPC

Respiratory, Preventive immunization/medic

1.5

8.3

229

1099

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.4

8.3

787

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

0.9

8.3

1929

16079

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.5

8.2

248

1212

Q90.9

ICD-10 Finland

Down syndrome, unspecified

73.2

8.2

F0014, G309,

ICD-10 Finland

73.2

8.2

TGC00

NOMESCO Finland

Bronchial lavation

0.6

8.2

119

1504

K90

ICPC

Stroke/cerebrovascular accident

1.4

8.2

447

2434

K91

ICPC

Cerebrovascular disease

1.6

8.2

203

951

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

5.3

8.1

R10.1

ICD-10 Finland

Pain localized to upper abdomen

0.8

8.1

1283

11038

D10

ICPC

Vomiting

1.5

8.1

253

1246

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

0.6

8.1

127

1571

T11

ICPC

Dehydration

3.3

8.0

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

0.2

8.0

305

K31

ICPC

Cardiovascular, Medical examin/health eval partial

1.9

8.0

355

XF600, ,

SPAT

1.4

8.0

308

1580

N05AL01

ATC

sulpiride; systemic

1.7

8.0

147

639

ACC51

NOMESCO Finland

Release of median nerve

0.7

8.0

377

3738

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

0.5

7.9

1189

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.6

7.9

167

752

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

7.9

129

1581

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

7.9

643

3702

M19.0

ICD-10 Finland

Primary arthrosis of other joints

0.8

7.9

675

6183

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

0.7

7.9

239

2558

R05

ICPC

Cough

0.9

7.8

1929

16019

G46.8

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

5.1

7.8

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.1

7.8

209

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

7.8

866

7707

NG2AA

NOMESCO Finland

Patella X-ray examination

0.6

7.8

133

1611

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

0.8

7.8

631

5815

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

7.8

1528

9635

B01AA03

ATC

warfarin; systemic

1.1

7.7

3949

26567

L86

ICPC

Back syndrome with radiating pain

0.7

7.7

350

3492

L12

ICPC

Hand/finger symptom/complaint

0.8

7.7

1090

9474

C08CA13

ATC

lercanidipine; oral

0.9

7.7

1608

13522

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

0.3

7.7

550

S01.7

ICD-10 Finland

Multiple open wounds of head

2.1

7.7

275

R05

ICD-10 Finland

Cough

0.9

7.7

1781

14859

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

7.7

350

3490

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.7

7.7

249

2630

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.5

7.7

252

1255

ZX080

NOMESCO Finland

Image guided radiotherapy

0.5

7.7

1002

SPA02

NOMESCO Finland

Preparation for dental prosthetics

0.6

7.6

116

1447

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.8

7.6

453

4345

L02BG06

ATC

exemestane; oral

0.4

7.6

740

XCW10, ,

SPAT

0.2

7.6

252

SPAT1043

SPAT

Audiometry

0.8

7.6

1167

10068

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

0.2

7.6

237

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.2

7.6

223

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

9.0

7.6

K85

ICPC

Elevated blood pressure

0.9

7.6

1780

14833

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

0.7

7.5

297

3030

P99

ICPC

Psychological disorders other

1.8

7.5

117

485

T90.5

ICD-10 Finland

Sequelae of intracranial injury

1.9

7.5

338

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.4

7.5

703

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

7.5

1243

B01AF01

ATC

rivaroxaban; oral

0.8

7.5

1339

11401

TFP34

NOMESCO Finland

Electrophysiological investigation

0.5

7.5

1147

Z43.5

ICD-10 Finland

Attention to cystostomy

1.8

7.5

104

417

HAMTE, ,

NOMESCO Finland

2.1

7.4

249

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.9

7.4

1452

12277

L01AX03

ATC

temozolomide; systemic

0.1

7.4

180

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

0.6

7.4

108

1361

G04BD10

ATC

darifenacin; oral

1.8

7.4

101

402

P71

ICPC

Organic psychosis other

7.8

7.4

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.8

7.4

116

482

L02BA01

ATC

tamoxifen; oral

0.6

7.4

174

1957

R81

ICPC

Pneumonia

1.4

7.4

393

2132

G04BD12

ATC

mirabegron; oral

1.2

7.4

1694

10814

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.5

7.4

1152

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.4

7.3

666

F0001, G301,

ICD-10 Finland

65.9

7.3

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

1.6

7.3

148

660

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

7.3

987

SPAT1081

SPAT

Cardiorespiratory global assessment

1.2

7.3

782

4655

P15

ICPC

Chronic alcohol abuse

1.7

7.3

129

556

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.9

7.3

1716

14298

SGA02

NOMESCO Finland

Opening and preparing the root canals

0.8

7.3

620

5677

F30.1

ICD-10 Finland

Mania without psychotic symptoms

4.5

7.3

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.6

7.2

174

1948

B01AC07

ATC

dipyridamole; systemic

1.2

7.2

999

6102

N81.1

ICD-10 Finland

Cystocele

0.8

7.2

460

4369

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

0.6

7.2

148

1715

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

2.4

7.2

153

S32.4

ICD-10 Finland

Fracture of acetabulum

1.8

7.2

104

422

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.5

7.1

771

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.5

7.1

227

1124

F16

ICPC

Eyelid symptom/complaint

0.7

7.1

257

2662

180

Kela drug reimbursment

Interferon alfa

0.1

7.1

211

L04AX01

ATC

azathioprine; systemic

0.6

7.1

158

1798

SPAT1109

SPAT

Analgesia with portable analgesic pump

1.9

7.1

340

R5140

NOMESCO Finland

Monitoring the use of the aid

0.8

7.1

703

6328

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

1.4

7.1

258

1313

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.3

7.0

536

3062

B01AC24

ATC

ticagrelor; oral

0.7

7.0

200

2161

N80

ICPC

Head injury other

1.5

7.0

190

910

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.2

7.0

202

CS494

NOMESCO Finland

Other visual field testing

0.6

7.0

129

1530

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.5

7.0

1019

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

0.2

7.0

386

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

0.7

7.0

332

3285

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

7.0

522

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.1

6.9

4591

31276

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

3.6

6.9

T89

ICPC

Diabetes insulin dependent

1.5

6.9

234

1174

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.1

6.9

237

H02BX01

ATC

methylprednisolone, combinations; systemic

1.2

6.9

732

4352

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

8.4

6.9

E87.6

ICD-10 Finland

Hypokalaemia

1.3

6.9

390

2138

A04AD12

ATC

aprepitant; systemic

0.4

6.9

615

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.8

6.9

1128

9673

G03FB05

ATC

norethisterone and estrogen; systemic

0.8

6.9

692

6218

XX2RW, ,

NOMESCO Finland

0.3

6.8

405

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

6.8

428

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

0.2

6.8

369

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.5

6.8

737

ZXC96

NOMESCO Finland

Robot assisted procedure

0.5

6.8

1068

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.3

6.8

419

2326

E66

ICD-10 Finland

Obesity

0.5

6.8

1077

EBA00

NOMESCO Finland

Extraction of tooth

1.1

6.8

3363

22559

SXA20

NOMESCO Finland

Local application of medicine to mouth

0.6

6.8

159

1787

Y94.8

ICD-10 Finland

Other leisure activity accident

1.4

6.8

243

1233

K22

ICPC

Risk factor cardiovascular disease

0.8

6.8

475

4453

-, ,

ICD-10 Finland

1.4

6.8

263

1355

R00.2

ICD-10 Finland

Palpitations

0.7

6.7

366

3551

A02BC04

ATC

rabeprazole; oral

0.8

6.7

460

4327

H43.8

ICD-10 Finland

Other disorders of vitreous body

0.8

6.7

617

5602

M05BA07

ATC

risedronic acid; oral

1.3

6.7

471

2663

B04AB02, ,

ATC

1.4

6.7

353

1915

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.6

6.7

135

603

Z51.0

ICD-10 Finland

Radiotherapy session

0.5

6.7

741

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

0.8

6.7

464

4355

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

6.7

623

3651

JN3AD

NOMESCO Finland

Abdominal CT examination

0.8

6.7

908

7919

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.8

6.7

606

5508

SPAT1127

SPAT

Enema

1.6

6.7

134

598

SPAT1098

SPAT

Exercise ECG

0.6

6.7

1201

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

1.7

6.7

107

449

F0022, G301,

ICD-10 Finland

32.9

6.6

J01FA09

ATC

clarithromycin; systemic

0.9

6.6

2237

18204

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

2.1

6.6

212

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

6.6

318

3139

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

0.1

6.5

145

G03CA04

ATC

estriol; systemic, vaginal

1.2

6.5

1180

7388

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.5

6.5

694

W10

ICD-10 Finland

Fall on and from stairs and steps

1.3

6.5

533

3075

K03.00

ICD-10 Finland

Approximal wear

0.7

6.5

231

2396

N02BF02

ATC

pregabalin; oral

0.7

6.5

269

2719

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.6

6.5

159

745

R4190

NOMESCO Finland

Nutritional therapy

0.6

6.5

1174

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

0.6

6.5

110

1330

C09DA01

ATC

losartan and diuretics; oral

0.8

6.5

992

8557

F0002, G300,

ICD-10 Finland

58.6

6.5

R12

ICD-10 Finland

Heartburn

0.8

6.5

433

4081

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

0.3

6.5

459

F0024, G309,

ICD-10 Finland

+∞

6.4

F0003, G300,

ICD-10 Finland

+∞

6.4

R35

ICD-10 Finland

Polyuria

1.2

6.4

856

5212

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

1.9

6.4

336

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

0.4

6.4

639

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.4

1102

6869

JN6AD

NOMESCO Finland

CT of torso and neck

0.5

6.4

720

OAB44, ,

SPAT

0.7

6.4

313

3084

XX1XN

NOMESCO Finland

Other isotope examination

0.2

6.4

267

F32.0

ICD-10 Finland

Mild depressive episode

1.6

6.4

148

684

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

0.6

6.4

1114

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

0.8

6.4

391

3730

A64

ICPC

General and Unspecified, Encounter/prob initiated by provider

2.9

6.4

R96

ICPC

Asthma

0.8

6.4

669

5986

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.9

6.4

5918

45707

PD5AD

NOMESCO Finland

CT of aorta

0.6

6.4

120

1415

M76.0

ICD-10 Finland

Gluteal tendinitis

0.5

6.4

787

SXC05

NOMESCO Finland

Other oral or dental procedure

0.7

6.4

211

2215

XJH00

NOMESCO Finland

Transanal ultrasonography

1.2

6.4

1013

6274

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

0.2

6.3

340

R41.2

ICD-10 Finland

Retrograde amnesia

3.3

6.3

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

0.8

6.3

500

4618

K03.11

ICD-10 Finland

Abrasion dentifrice of teeth

0.5

6.3

950

WVA40, ,

SPAT

2.1

6.3

201

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

1.7

6.3

122

539

F01

ICD-10 Finland

Vascular dementia

1.9

6.3

281

ZY000

NOMESCO Finland

Hospital inpatient

2.1

6.3

221

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

0.8

6.3

806

7067

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.1

6.3

3675

24860

N03AF02

ATC

oxcarbazepine; oral

1.4

6.3

269

1412

S02.51

ICD-10 Finland

Fracture of tooth, open

0.8

6.2

443

4145

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

0.3

6.2

429

L04AX03

ATC

methotrexate; systemic

0.8

6.2

540

4934

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.5

6.2

161

764

F38

ICPC

Eye, Other laboratory test NEC

0.5

6.2

781

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

2.1

6.2

217

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

6.2

159

1754

M79.6

ICD-10 Finland

Pain in limb

0.9

6.2

3937

30962

N18.0

ICD-10 Finland

End-stage renal disease

0.5

6.2

731

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.8

6.2

445

4159

M05BA02

ATC

clodronic acid; systemic

0.3

6.2

371

A96

ICPC

Death

1.8

6.2

372

XG474

NOMESCO Finland

Exhalation nntrogen oxide

0.5

6.2

838

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

0.2

6.2

249

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

6.2

100

421

JF1AD

NOMESCO Finland

Small bowel CT

0.2

6.2

250

AA1FD

NOMESCO Finland

Trauma CT of head and face

3.2

6.2

R03BB04

ATC

tiotropium bromide; inhalant

0.9

6.2

1200

10151

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.4

6.2

313

1689

SPF30

NOMESCO Finland

Relining of denture

1.4

6.2

251

1306

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

4.5

6.1

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

0.4

6.1

544

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.7

6.1

333

3229

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.5

6.1

647

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

0.7

6.1

221

2285

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.2

6.1

787

4777

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.9

6.1

269

C09AA05

ATC

ramipril; oral

1.1

6.1

4070

27702

K30

ICD-10 Finland

Functional dyspepsia

0.8

6.1

715

6325

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

6.2

6.1

A84

ICPC

Poisoning by medical agent

6.2

6.1

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.0

6.1

249

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.7

6.1

160

1753

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.3

6.1

366

2028

A98

ICPC

Health maint/preventive medicine

1.1

6.1

11688

83401

Z27

ICPC

Fear of a social problem

2.5

6.1

107

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.5

6.1

173

840

A34

ICPC

General and Unspecified, Blood test

1.6

6.0

154

729

TFP20

NOMESCO Finland

Cardiodefibrillation

0.8

6.0

746

6565

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.0

399

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

0.7

6.0

259

2600

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

0.6

6.0

116

1359

C01DA14

ATC

isosorbide mononitrate; oral

1.1

6.0

3488

23577

R4135

NOMESCO Finland

Rehabilitation for hearing problems

0.7

6.0

155

1705

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

0.6

6.0

1028

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

793

391

15.58

307.65

1.0

55.74

36.14

ng/l

16.20

581

224

(3019309) Folate [Moles/volume] in Red Blood Cells

5922

23459

2.37

307.65

1.9

1.8

1200.82

1156.54

nmol/l

2.83

4291

17234

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

793

391

15.58

307.65

1.0

561.00

736.02

ng/l

10.14

577

218

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

783

392

15.34

307.65

1.0

408.94

270.94

ng/l

18.56

581

229

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

795

1475

4.10

251.97

1.2

1.3

474.97

592.18

mg/l

4.66

716

1400

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

718

1242

4.39

248.48

1.3

1.4

279.34

1182.55

e6/l

4.03

562

1041

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

717

1241

4.38

247.95

1.2

1.3

10.25

22.64

e6/l

1.00

545

984

(3021960) Folate [Moles/volume] in Serum or Plasma

5467

26000

1.83

245.91

1.7

1.6

20.42

20.29

nmol/l

0.20

4813

21673

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

719

1275

4.28

241.23

1.2

3.84

3.89

mmol/l

0.55

674

1183

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7949

43090

1.72

219.94

2.5

2.2

90.48

93.06

pmol/l

4.90

4131

21992

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4357

20026

1.82

212.23

3.0

3.1

2.46

2.47

mmol/l

10.27

3788

17128

(3044290) Cell count panel - Cerebral spinal fluid

621

1158

4.05

194.96

1.2

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6330

33176

1.67

188.30

2.6

3.2

2.35

mmol/l

0.01

5377

27945

(3009466) Valproate [Moles/volume] in Serum or Plasma

460

824

4.18

151.82

3.2

3.8

316.36

329.64

umol/l

0.98

365

676

(3023410) Appearance of Cerebral spinal fluid

335

504

4.95

135.88

1.3

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7493

43202

1.52

131.60

3.7

4.5

34.34

34.07

g/l

3.83

6698

39396

(3031040) Bacteria [#/volume] in Urine by Automated count

10005

61381

1.54

131.46

6.2

5.5

2958.51

1426.22

e6/l

1.87

332

999

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4320

22363

1.57

121.16

1.8

5311200.06

24430961.53

pmol/l

3.73

3427

17560

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2725

12649

1.70

117.72

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2722

12709

1.69

114.75

1.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

6167

34993

1.48

109.94

3.9

3.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6240

35673

1.47

105.82

2.1

2.2

77.76

81.07

nmol/l

14.06

5287

30405

(40768804) Tissue Pathology biopsy report

3374

34255

0.64

103.41

2.2

2.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3613

18513

1.56

102.88

1.9

—

(3023368) Bacteria identified in Blood by Culture

5474

30700

1.47

100.99

4.0

4.3

—

(3018418) pH of Serum or Plasma

5313

30165

1.44

88.77

3.1

4.0

7.40

0.82

810

5785

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7593

46029

1.41

87.23

4.6

5.9

1.22

1.21

mmol/l

8.32

6732

41154

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8226

50964

1.39

80.06

5.2

6.6

1.22

1.21

mmol/l

21.16

6836

42528

(3020682) Albumin/Creatinine [Ratio] in Urine

3313

31782

0.70

67.43

3.2

3.8

10.88

10.06

mg/mmol

0.39

2033

19862

(3016018) Differential panel - Cerebral spinal fluid

270

596

3.36

66.59

1.2

1.3

—

(3019150) Specific gravity of Urine by Refractometry

3487

19120

1.43

66.27

5.4

5.0

1.02

kg/l

0.60

527

3227

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5636

33529

1.36

65.86

2.5

2.1

—

(3012516) Albumin [Mass/volume] in Urine

3114

29885

0.70

62.26

2.7

3.2

497.89

393.20

mg/l

0.56

1938

19075

(3009508) Creatinine [Moles/volume] in Urine

3134

29983

0.71

61.29

2.6

3.1

6.84

6.70

mmol/l

1.14

2460

24251

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8833

72124

0.76

56.76

3.5

4.3

1.20

1.24

mmol/l

6.79

7429

62646

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1386

6523

1.61

53.47

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9221

74525

0.77

51.76

4.0

4.8

1.45

mmol/l

0.28

7904

65526

(4035726) Immunohistochemistry procedure

626

8297

0.53

50.55

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

939

11067

0.60

49.21

1.2

15.99

15.93

u/ml

0.01

243

3583

(3003338) MCHC [Mass/volume]

9199

60331

1.28

46.19

27.3

26.2

329.84

330.21

g/l

3.38

8970

59567

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9406

75401

0.78

45.63

4.0

4.9

4.30

4.34

mmol/l

3.05

8118

66906

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6370

39955

1.28

45.38

4.7

4.5

57.89

90.75

ng/l

1.71

5078

32215

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5006

30506

1.30

44.36

2.3

2.1

270.78

217.99

u/l

3.24

4628

28241

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2087

20415

0.71

43.51

1.5

1.6

1.21

1.27

mmol/l

5.07

1812

16531

(1761868) Lipid panel - Serum or Plasma

1917

18914

0.70

41.80

3.3

3.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

797

3502

1.70

39.82

1.2

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4576

27872

1.29

39.57

2.3

2.4

2.99

3.19

mg/l

6.04

3713

23441

(3015736) pH of Urine

5506

34320

1.27

39.49

4.3

4.1

6.00

5.86

0.94

103

890

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1083

11784

0.65

39.34

1.2

1.3

40.92

42.67

iu/ml

0.13

313

3618

(3037467) Urinalysis macro (dipstick) panel - Urine

9267

61421

1.26

38.95

5.2

5.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1420

7201

1.49

38.61

1.9

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11733

80084

1.30

38.35

20.2

19.2

32.08

27.98

mg/l

24.77

10124

66964

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

129

254

3.74

37.75

1.2

42.43

64.48

—

(3035350) Ketones [Presence] in Urine by Test strip

6669

42757

1.25

36.60

4.7

4.4

0.00

estimate

0.08

1153

8939

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

545

6850

0.57

36.00

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9363

74288

0.80

35.05

19.6

18.7

67.06

67.82

ml/min/173m2

2.94

7418

62028

(3029937) Albumin [Presence] in Urine by Test strip

3912

23735

1.28

33.74

5.2

4.8

0.00

estimate

1.34

921

7650

(3013826) Glucose [Moles/volume] in Serum or Plasma

8371

55338

1.23

33.24

4.6

4.7

7.09

6.92

mmol/l

7.96

7874

52106

(3037522) Nuclear Ab [Titer] in Serum

822

9155

0.64

32.92

1.2

1.3

497.57

533.29

titre

0.24

173

2153

(3009261) Glucose [Presence] in Urine by Test strip

6672

43174

1.23

31.98

4.7

4.5

0.00

estimate

1.08

1004

8006

(3002179) Metamyelocytes/100 leukocytes in Blood

597

7103

0.60

31.76

3.1

3.7

0.67

0.69

0.06

176

2517

(3017181) Myelocytes/100 leukocytes in Blood

688

7884

0.62

31.23

3.2

3.7

1.12

0.94

0.53

230

2952

(3021440) Promyelocytes/100 leukocytes in Blood

647

7498

0.62

30.81

3.3

3.8

0.15

0.10

0.84

192

2588

(3021601) Nitrite [Presence] in Urine by Test strip

6576

42602

1.22

30.72

6.0

5.9

0.00

estimate

0.50

1000

8112

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5112

32263

1.24

30.62

5.2

4.9

—

(3002256) Pathology report gross observation

1177

11961

0.70

29.33

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1144

11660

0.70

28.96

4.2

5.0

34.83

34.24

0.88

630

7434

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9955

77935

0.82

28.80

4.7

5.6

2.43

2.47

mmol/l

4.86

8643

68926

(3011397) Hemoglobin [Presence] in Urine by Test strip

3452

21040

1.26

27.66

4.6

4.3

—

(3022145) Colonoscopy Study observation

873

9216

0.67

26.61

1.2

1.3

—

(3025159) Blasts/100 leukocytes in Blood

614

6969

0.63

26.57

3.2

3.8

0.07

0.46

3.46

161

2114

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8880

59759

1.20

26.16

3.7

4.0

15.24

15.26

pmol/l

0.24

7714

52219

(3026493) Urate [Moles/volume] in Serum or Plasma

2718

24115

0.79

26.09

2.4

2.9

8429.33

7085.64

umol/l

0.56

2155

20111

(3013512) EKG study

3499

30173

0.80

26.06

4.5

4.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10662

73094

1.22

25.45

4.9

5.0

2.04

2.12

mu/l

2.74

9444

64366

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3350

20675

1.24

23.37

4.4

219.14

432.85

ng/l

3.43

3043

18407

(40768797) Stomach Pathology biopsy report

1253

12092

0.74

22.27

1.2

—

(3003694) ABO and Rh group [Type] in Blood

2128

19095

0.79

21.87

1.2

1.3

—

(3000492) Spirometry study

530

5931

0.64

21.40

1.5

1.6

—

(4200892) Spirometry reversibility

575

6309

0.65

21.14

1.4

—

(3021589) Normoblasts [#/volume] in Blood

4410

36561

0.84

20.67

9.6

10.9

0.00

e9/l

1.29

3488

29643

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5039

41266

0.84

20.43

2.5

2.8

—

(40761535) Cells panel - Urine sediment

1520

8647

1.32

20.40

3.8

3.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1280

7126

1.34

19.92

4.9

6.3

24.47

24.58

mmol/l

0.47

1227

6762

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

614

6548

0.67

19.54

1.5

—

(3018095) Leukocytes [#/volume] in Urine

5296

34625

1.18

19.31

4.3

4.1

200.44

134.89

e6/l

1.98

3836

25625

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

592

2.18

19.28

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

856

4487

1.42

19.24

1.5

1.65

1.64

0.02

701

3569

(3019832) Treponema pallidum Ab [Presence] in Serum

333

1408

1.75

19.19

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

388

4529

0.62

18.91

1.9

1.80

1.41

g/l

0.84

308

4000

(40761511) CBC panel - Blood by Automated count

11500

80141

1.19

18.87

19.4

18.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

175

3.23

18.47

1.3

1.2

34.80

23.42

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

294

3639

0.58

18.20

2.6

4.0

215.23

95.25

u/ml

1.25

272

3472

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1268

11877

0.76

18.00

2.7

3.7

17.57

22.19

ug/l

0.34

1018

9932

(3022217) INR in Platelet poor plasma by Coagulation assay

7547

50961

1.16

17.80

20.6

21.6

1.40

1.43

inr

0.96

1725

14217

(3019550) Sodium [Moles/volume] in Serum or Plasma

12031

84313

1.20

17.74

24.5

23.3

139.65

139.44

mmol/l

10.25

11565

81922

(3023103) Potassium [Moles/volume] in Serum or Plasma

12038

84388

1.20

17.55

24.5

23.5

4.01

mmol/l

1.69

11548

81873

(40760892) CBC W Ordered Manual Differential panel - Blood

4877

39629

0.85

16.90

4.7

6.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

533

2617

1.51

16.81

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1402

8091

1.29

16.80

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1373

12613

0.78

16.69

1.5

2.74

2.75

g/l

0.02

633

6780

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

532

2617

1.50

16.64

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

479

5192

0.66

16.55

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

134

437

2.25

16.20

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

635

6494

0.70

16.02

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

4711

30899

1.17

15.63

3.7

3.6

139.84

115.10

e6/l

0.32

3648

24189

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1780

10667

1.25

15.61

2.5

5.51

6.13

ug/l

0.90

1308

8946

(3010813) Leukocytes [#/volume] in Blood

12093

85077

1.18

15.26

28.5

28.4

7.25

7.04

e9/l

8.15

11483

81731

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

159

571

2.05

15.15

1.1

—

3.34

—

(4094501) Cardiovascular stress test using bicycle ergometer

138

2016

0.50

15.09

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

12085

85047

1.18

15.01

28.6

28.5

37.79

38.61

26.29

10405

77615

(3035941) MCH [Entitic mass]

12085

85065

1.18

14.86

28.4

28.3

30.38

30.42

1.16

11653

83155

(3026361) Erythrocytes [#/volume] in Blood

12085

85069

1.18

14.83

28.6

28.4

4.23

4.31

e12/l

56.35

11462

81688

(3007461) Platelets [#/volume] in Blood

12083

85060

1.18

14.78

28.5

28.4

235.99

237.12

e9/l

1.01

11512

82101

(3024731) MCV [Entitic volume]

12084

85069

1.18

14.77

28.5

28.3

91.95

91.98

0.30

11657

83161

(3000963) Hemoglobin [Mass/volume] in Blood

12085

85079

1.18

14.75

28.8

28.6

127.51

130.25

g/l

72.29

11635

83189

(3018572) Chloride [Moles/volume] in Blood

467

2297

1.50

14.65

4.3

6.1

104.64

104.82

mmol/l

0.29

431

2041

(3039000) Anion gap in Blood

467

2297

1.50

14.65

4.3

6.1

11.26

11.34

mmol/l

0.17

431

2041

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

731

7163

0.73

14.13

2.7

2.9

57.00

55.95

ml/min/173m2

0.37

303

3352

(3005719) IgG [Mass/volume] in Serum or Plasma

553

5649

0.71

13.85

2.6

2.7

10.67

10.77

g/l

0.16

465

5107

(3052592) Norovirus Ag [Presence] in Stool

245

2.55

13.51

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2706

22679

0.85

13.04

2.3

2.5

—

(40768793) Breast Pathology biopsy report

122

1750

0.51

12.69

1.2

1.3

—

(40768443) Skin Pathology biopsy report

409

4330

0.68

12.54

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

279

3180

0.64

12.32

1.5

1.6

37.75

38.16

u/l

0.12

211

2622

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

286

3235

0.64

12.20

1.5

1.6

120.00

244.72

titre

2.10

159

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

195

2.63

11.95

1.5

—

(3047181) Lactate [Moles/volume] in Blood

611

3284

1.38

11.93

4.3

5.4

1.41

1.35

mmol/l

0.51

553

2908

(3018010) Neutrophils/100 leukocytes in Blood

5027

40069

0.88

11.91

4.8

5.6

60.74

59.51

9.36

4521

36784

(3019069) Monocytes/100 leukocytes in Blood

5049

40228

0.88

11.87

5.0

6.0

8.92

8.97

0.52

4532

36881

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

156

2035

0.56

11.86

1.5

1.7

12.87

12.56

mg/l

0.16

134

1830

(3006504) Eosinophils/100 leukocytes in Blood

5023

40016

0.88

11.75

4.7

5.7

2.82

2.79

0.26

4507

36655

(3009445) Proteinase 3 Ab [Units/volume] in Serum

399

4190

0.69

11.72

1.3

1.5

51.73

18.69

u/ml

—

(3022096) Basophils/100 leukocytes in Blood

4877

38920

0.88

11.71

4.7

5.7

0.60

0.63

1.93

4364

35648

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

235

2746

0.62

11.61

1.5

1.4

21.80

16.73

iu/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

2235

0.58

11.59

1.7

2.8

197.40

829.39

u/ml

2.50

154

2027

(36304419) Bacteria [Presence] in Urine

4071

26884

1.15

11.52

3.5

—

(3013115) Eosinophils [#/volume] in Blood

5524

43671

0.88

11.28

4.6

5.5

0.20

e9/l

0.52

4553

37230

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1520

13253

0.82

11.23

2.7

3.6

248.91

251.76

u/l

0.28

1333

12365

(3006315) Basophils [#/volume] in Blood

5362

42457

0.88

11.21

4.5

5.3

0.04

e9/l

1.10

4419

35750

(3001604) Monocytes [#/volume] in Blood

5337

42270

0.88

11.21

4.5

5.3

0.64

e9/l

0.32

4402

35565

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1074

0.41

11.20

1.3

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

223

2614

0.62

11.19

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

1044

9456

0.79

11.07

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

5146

40813

0.88

10.97

4.9

5.9

23.78

25.01

11.38

4625

37484

(3006270) Folate [Moles/volume] in Blood

219

972

1.66

10.79

1.2

319.77

309.29

nmol/l

0.28

169

717

(3014271) Vancomycin [Susceptibility]

204

889

1.69

10.77

3.4

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

127

1706

0.54

10.74

1.5

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

133

1756

0.55

10.61

1.2

3.48

4.91

u/ml

0.73

297

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1790

11158

1.20

10.45

3.3

3.2

249.96

282.24

ng/l

1.98

1646

10258

(3044640) Blood type and Crossmatch panel - Blood

3715

30001

0.88

10.40

2.4

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

132

1736

0.55

10.39

1.2

3.98

5.41

u/ml

0.22

192

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

173

2116

0.59

10.38

1.2

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

314

3363

0.68

10.29

1.2

1.3

250.09

244.26

u/ml

0.05

278

3030

(3013650) Neutrophils [#/volume] in Blood by Automated count

6316

49349

0.89

10.17

6.1

8.3

4.73

4.44

e9/l

12.19

5310

42358

(3020779) Urea [Moles/volume] in Serum or Plasma

1125

10008

0.81

10.10

4.1

5.9

11.69

12.09

mmol/l

0.92

1017

9314

(3019198) Lymphocytes [#/volume] in Blood

5483

43174

0.89

10.08

4.6

5.4

1.73

1.87

e9/l

3.57

4567

37146

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

169

715

1.74

9.96

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9876

75200

0.89

9.82

6.4

7.0

42.24

41.39

mmol/mol

11.16

8641

67180

(3015171) Extractable nuclear Ab [Units/volume] in Serum

231

2598

0.65

9.68

1.2

0.49

0.95

u/ml

1.01

256

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

721

0.34

9.57

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

587

5610

0.76

9.56

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

380

1962

1.43

9.46

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

153

1880

0.59

9.39

4.0

3.4

2.09

1.51

0.71

122

1607

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

1505

0.55

9.35

1.2

2.16

5.61

u/ml

1.02

121

(3020191) Ethanol [Moles/volume] in Serum or Plasma

103

380

1.99

9.32

1.2

0.71

1.02

promille

1.55

276

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

151

1851

0.59

9.20

1.2

30.68

41.69

u/ml

0.17

103

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2528

16400

1.15

8.92

3.3

3.2

2.70

2.69

e6/l

0.03

1380

9341

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

186

2150

0.63

8.87

1.5

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

654

3720

1.30

8.79

1.9

2.2

1084.37

536.75

ug/l

0.96

607

3505

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1112

0.49

8.78

1.2

—

(40768795) Lymph node Pathology biopsy report

880

0.43

8.76

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

1160

0.50

8.76

3.1

3.5

57.71

58.13

0.05

934

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

309

2.07

8.75

1.1

38.84

45.71

mg/l

0.89

265

(3017143) Hepatitis C virus Ab [Presence] in Serum

572

5414

0.76

8.69

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

128

522

1.80

8.61

1.2

2.04

2.24

mmol/l

1.77

118

470

(3042631) Mycobacterium sp identified in Specimen

142

1733

0.60

8.53

2.2

2.7

—

(4281824) Cell count and differential, peritoneal fluid

918

0.45

8.45

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

113

1459

0.56

8.42

1.1

—

(40757373) Influenza virus identified in Isolate

213

2.27

8.41

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

144

1743

0.60

8.38

1.1

84.00

145.62

titre

—

112

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

166

1940

0.62

8.33

2.3

2.1

209.22

213.69

0.26

152

1825

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

1390

0.56

8.17

3.6

3.5

229.40

2532.26

iu/ml

1.05

195

(21494755) Public health laboratory ask at order entry panel

785

0.43

7.96

1.2

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

138

1663

0.60

7.91

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

3329

22149

1.13

7.90

2.8

5.71

5.06

e6/l

2.10

3001

19794

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

270

0.19

7.80

1.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

840

7489

0.81

7.70

1.7

1.9

171.34

176.35

ug/g

0.12

611

5672

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9641

67875

1.10

7.61

5.6

7.6

81.37

82.84

u/l

1.47

8760

63248

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1619

10283

1.17

7.52

4.6

6.4

119.85

118.65

g/l

1.61

1574

9984

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

2160

0.66

7.40

1.4

1.5

1.14

1.15

g/l

0.19

177

2020

(3040151) Glucose [Moles/volume] in Capillary blood

272

1386

1.44

7.37

10.1

13.5

7.73

7.36

mmol/l

0.85

219

1135

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

185

2048

0.66

7.30

1.8

1.9

89.79

87.18

1.02

173

1959

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

286

2.00

7.28

1.0

1.1

276.49

325.85

mg/l

1.13

250

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

192

2107

0.66

7.26

1.3

1.4

0.23

g/l

0.07

172

1964

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

267

2.03

7.22

3.1

2.8

27.11

29.50

umol/l

1.15

199

(3023419) Bacteria identified in Sputum by Culture

144

1675

0.63

7.15

2.0

2.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

430

4111

0.76

7.10

2.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

407

2237

1.34

7.06

4.1

3.9

31.49

30.42

mg/l

0.21

305

1495

(3024980) IgG subclass 4 [Mass/volume] in Serum

1013

0.52

7.05

1.5

1.6

0.70

0.86

g/l

0.57

761

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

104

2.68

6.87

1.1

1.2

19.36

47.86

2.51

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

339

1.88

6.85

1.7

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

339

1.88

6.85

1.7

2.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1678

13940

0.87

6.79

3.5

5.0

1.03

1.04

mmol/l

1.32

1438

12629

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1910

12379

1.15

6.74

10.2

9.2

—

(3004616) Nuclear Ab [Presence] in Serum

966

0.53

6.67

1.1

1.3

—

(3003396) Base excess in Arterial blood by calculation

1982

12892

1.14

6.63

4.3

5.8

1.26

1.17

mmol/l

0.42

1481

10080

(3024354) Oxygen [Partial pressure] in Venous blood

1405

8913

1.17

6.62

2.5

3.1

4.15

4.35

kpa

3.33

1331

8580

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2650

17563

1.13

6.59

3.0

1.59

1.44

e6/l

0.39

1484

10431

(3016502) Oxygen saturation in Arterial blood

1777

11480

1.15

6.56

4.4

6.0

94.93

95.13

0.52

1703

10979

(3023183) Ammonium ion [Moles/volume] in Plasma

342

1853

1.36

6.54

1.5

2.0

26.42

32.55

umol/l

5.62

280

1581

(3018405) Lactate [Moles/volume] in Arterial blood

678

4022

1.24

6.54

2.9

3.7

1.46

1.41

mmol/l

0.44

666

3942

(3019060) Gas panel - Arterial blood

1236

7769

1.18

6.53

3.5

4.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

177

1929

0.67

6.51

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

418

2337

1.32

6.48

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

952

0.54

6.38

2.0

3.6

34.83

55.71

u/ml

1.67

925

(3030467) Casts [#/volume] in Urine by Automated count

4176

28415

1.10

6.36

3.5

0.61

0.51

e6/l

1.55

3243

22266

(3045142) Bone marrow Pathology biopsy report

1119

0.57

6.32

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10313

77721

0.91

6.29

4.7

5.4

6.21

6.13

mmol/l

4.74

8831

67960

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

408

3859

0.77

6.26

2.3

2.9

298.43

2705.57

u/ml

2.44

317

3268

(3008898) HLA-B27 [Presence]

1113

0.58

6.21

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

211

2203

0.70

6.19

1.8

2.1

3.65

3.67

g/l

0.05

196

2077

(3014765) Yersinia sp identified in Stool by Organism specific culture

419

2368

1.30

6.04

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

419

2373

1.30

5.95

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

132

1496

0.64

5.91

1.6

1.7

17.05

23.59

ug/l

2.39

126

1452

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.49

5.88

1.0

1.3

53.55

45.26

0.25

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1112

0.59

5.83

1.3

0.13

0.28

nmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3208

21623

1.11

5.82

4.4

4.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1107

0.59

5.74

1.3

0.69

0.71

nmol/l

0.16

1049

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.18

5.65

1.1

1.2

1.75

2.17

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

103

1220

0.62

5.64

1.2

75.76

46.95

u/ml

—

139

(40768800) Prostate Pathology biopsy report

218

2223

0.71

5.62

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.77

5.58

1.1

1.3

14.70

14.56

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1029

0.59

5.48

1.4

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

287

1.84

5.38

1.2

1.5

87.79

92.57

umol/l

0.09

169

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

642

0.49

5.33

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

680

0.50

5.30

3.1

3.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

364

3410

0.78

5.25

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

123

573

1.57

5.24

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

217

2183

0.72

5.18

2.4

2.5

1.80

1.88

mg/l

0.58

172

1907

(40768441) Liver Pathology biopsy report

494

0.43

5.16

1.0

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1954

12897

1.12

5.16

4.4

5.8

4.94

5.06

kpa

5.94

1844

12150

(3027801) Oxygen [Partial pressure] in Arterial blood

1952

12888

1.12

5.12

4.4

5.8

11.31

11.69

kpa

2.67

1841

12132

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

287

1.81

5.10

2.6

2.1

62.04

52.18

umol/l

1.41

231

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

159

794

1.47

4.94

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

320

3020

0.77

4.91

1.5

1.6

—

(3022621) pH of Urine by Test strip

1013

6420

1.17

4.88

4.0

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1457

9477

1.14

4.87

3.9

5.4

1.52

1.38

mmol/l

4.89

1400

9153

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

774

4801

1.19

4.85

3.8

4.6

1.68

1.54

1.78

734

4515

(3007930) Methemoglobin/Hemoglobin.total in Blood

766

4748

1.19

4.84

3.8

4.6

0.92

0.86

3.90

726

4458

(3011985) Renin [Units/volume] in Plasma

1036

0.62

4.76

1.2

1.3

49.84

50.75

mu/l

0.02

899

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

156

783

1.46

4.74

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

120

1318

0.66

4.72

2.6

3.5

29.91

45.26

u/ml

1.36

111

1277

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

284

1.78

4.71

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1109

0.64

4.63

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2116

14120

1.11

4.59

2.1

2.3

1.72

1.77

1.22

1693

12229

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

192

1010

1.40

4.54

1.5

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

248

1360

1.34

4.53

1.7

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

613

0.52

4.48

2.0

2.2

29.60

92.47

ug/min

—

149

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

116

1268

0.67

4.48

1.4

1.5

74.85

63.95

3.28

780

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1062

0.64

4.43

1.7

2.0

679.20

1630.44

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

370

3382

0.80

4.40

1.1

69.26

129.71

iu/ml

3.35

119

1102

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1777

14320

0.90

4.38

1.2

1.83

1.72

u/ml

0.11

395

3341

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

106

1171

0.66

4.33

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

634

0.54

4.31

2.6

1.7

0.96

1.04

e9/l

0.37

583

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5022

34912

1.08

4.31

2.7

3.0

143.07

158.81

ug/l

4.24

4335

31041

(21494890) Protein electrophoresis panel - 24 hour Urine

119

1283

0.68

4.30

2.0

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

951

0.63

4.21

1.3

1.2

115.25

127.29

u/ml

0.45

215

(3028707) Methadone [Presence] in Urine by Screen method

104

2.25

4.19

1.2

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

886

0.62

4.18

1.1

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

1.95

4.17

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1714

13801

0.90

4.16

1.9

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

728

0.58

4.13

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

447

2676

1.23

4.11

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

105

2.23

4.10

2.1

2.2

149.16

131.31

nmol/l

0.41

(21494434) Karyotype in Bone marrow

988

0.64

4.08

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

168

1687

0.73

4.06

2.6

3.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

208

0.32

4.03

1.0

1.4

132.62

143.63

pmol/l

—

208

(3028717) Thiamine [Mass/volume] in Blood

2.59

4.03

1.0

1.2

—

(4034850) Laboratory test

451

2711

1.22

4.00

12.7

13.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

961

0.65

3.92

1.1

1.2

228.32

262.01

pmol/l

0.93

791

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

194

0.30

3.91

3.8

1.8

—

(40765096) Chromosome analysis panel by Banding

296

0.37

3.88

1.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

449

0.49

3.86

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

121

1271

0.69

3.84

1.2

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2383

16137

1.09

3.83

1.6

1.9

29.71

30.24

3.41

2284

15642

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

666

0.58

3.82

1.1

113.95

115.79

0.17

567

(3024522) Salmonella sp identified in Specimen by Organism specific culture

123

1286

0.70

3.81

1.2

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

177

1742

0.74

3.78

2.6

3.5

61.15

59.39

1.00

177

1742

(3028192) IgG subclass 2 [Mass/volume] in Serum

636

0.57

3.78

1.2

1.3

2.69

2.89

g/l

0.38

449

(3027135) IgG subclass 1 [Mass/volume] in Serum

636

0.57

3.78

1.2

1.3

6.32

7.16

g/l

0.90

443

(3024139) IgG subclass 3 [Mass/volume] in Serum

636

0.57

3.78

1.2

1.3

0.42

0.47

g/l

0.33

449

(3039162) Centromere protein B Ab [Units/volume] in Serum

818

0.62

3.76

1.3

1.2

63.93

45.96

u/ml

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

561

3467

1.19

3.75

3.6

3.2

0.78

0.82

nmol/l

1.17

437

2693

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2414

19016

0.92

3.73

3.0

3.5

0.89

0.86

ug/l

0.35

1725

14161

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

215

2054

0.76

3.73

1.5

42.04

5.08

iu/ml

1.03

528

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1054

0.67

3.71

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

122

1268

0.70

3.67

1.2

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

134

1370

0.71

3.66

1.2

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

287

0.38

3.64

3.1

1.7

—

(3000012) Reticulocyte production index

207

1981

0.76

3.64

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

382

1.57

3.62

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

960

0.66

3.61

1.3

—

nmol/l

—

(3026782) Osmolality of Urine

3150

21643

1.08

3.58

3.1

3.2

552.60

533.30

mosm/kgh2o

6.24

2662

18515

(4146454) Self-monitoring of blood glucose

117

1219

0.70

3.58

2.5

2.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

123

1270

0.71

3.57

1.2

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

513

0.54

3.57

1.2

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

142

1.96

3.56

3.3

3.0

0.37

0.53

u/field

0.66

142

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

141

1422

0.72

3.56

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

1131

0.69

3.55

1.1

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

128

1311

0.71

3.55

1.2

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

805

0.63

3.53

1.4

1.8

4.43

4.82

mg/l

0.38

753

(3022313) Gas panel - Capillary blood

587

5015

0.85

3.53

3.2

3.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

123

1266

0.71

3.52

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

384

0.48

3.51

2.3

1.5

—

(4062490) Immunoglobulin typing, IgG

639

0.59

3.48

1.3

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

741

6212

0.87

3.48

2.5

2.6

—

(3000330) Specific gravity of Urine by Test strip

699

5884

0.86

3.47

4.2

4.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

925

0.66

3.46

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

517

0.55

3.46

1.1

43.87

29.85

u/l

0.56

448

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

517

0.55

3.46

1.1

102.18

89.80

u/l

0.39

452

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

332

2979

0.81

3.42

1.8

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

789

5052

1.15

3.41

2.5

3.7

23.99

24.15

mmol/l

0.62

751

4892

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

849

0.65

3.37

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

849

0.65

3.37

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

849

0.65

3.37

1.2

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

417

0.51

3.36

1.3

1.1

0.29

0.84

u/ml

2.94

205

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1016

0.69

3.25

1.1

1.2

61.74

61.78

u/l

0.00

910

(3030981) Hyaline casts [#/volume] in Urine by Automated count

890

5768

1.14

3.23

3.4

2.9

0.44

0.31

e6/l

0.98

873

5667

(3037692) Legionella sp identified in Specimen by Organism specific culture

322

0.45

3.23

1.5

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

306

2750

0.81

3.22

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

1203

0.72

3.22

4.7

3.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

778

0.65

3.22

1.1

1.2

1.53

5.74

u/ml

3.15

246

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

391

0.50

3.22

1.1

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

391

0.50

3.22

1.1

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

524

0.57

3.22

1.0

1.1

97.44

90.56

1.41

474

(44813793) Dust mix specific IgE antibody measurement

361

0.49

3.20

1.0

1.1

—

(3002032) Base excess in Venous blood by calculation

1610

10802

1.10

3.16

2.7

3.6

1.99

1.95

mmol/l

0.15

1346

9036

(3045414) Leukocytes [Presence] in Urine

464

4000

0.84

3.15

2.2

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

511

0.57

3.14

1.2

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

149

0.29

3.14

12.5

12.9

5.80

5.29

mmol/l

—

149

(3021788) Differential panel - Synovial fluid

193

1823

0.77

3.14

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

406

0.52

3.12

1.0

273.26

294.14

mg/l

0.82

353

(3003434) Protein [Mass/volume] in Pleural fluid

226

2092

0.79

3.12

1.4

1.5

30.07

31.03

g/l

0.60

198

1852

(21494815) CD4 cells/100 lymphocytes in Specimen

500

0.57

3.11

2.2

1.7

37.72

37.10

0.11

485

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

987

0.69

3.07

1.0

—

(3045424) Erythrocytes [Presence] in Urine

151

1468

0.75

3.05

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

497

0.57

3.05

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

363

0.50

3.03

1.0

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1610

10826

1.10

3.03

2.7

3.6

5.84

5.83

kpa

0.08

1534

10469

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

3.01

0.0

1.1

—

(3020891) Body temperature

694

4450

1.15

2.98

3.6

4.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

208

0.35

2.98

1.0

0.04

0.89

u/ml

—

(3004775) Volume in Urine collected for unspecified duration

919

0.69

2.95

2.1

636.46

648.80

0.09

576

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

279

2501

0.81

2.91

1.8

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

607

0.63

2.88

1.1

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

257

0.43

2.88

3.1

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

185

1735

0.78

2.87

1.3

42.68

40.86

u/l

0.07

157

1484

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

164

1562

0.77

2.87

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

775

0.67

2.87

1.3

13.42

13.04

u/l

0.07

606

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

387

1.50

2.87

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

929

0.70

2.84

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

392

0.54

2.82

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

501

4249

0.86

2.81

2.6

3.0

50.97

85.09

mg/l

1.51

395

3445

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

709

5867

0.88

2.81

5.4

7.1

24.18

24.39

mmol/l

0.84

653

5562

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

692

0.65

2.81

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

788

0.68

2.80

1.6

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

131

1281

0.75

2.79

2.1

2.3

0.82

1.05

g/24h

0.48

601

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

483

0.59

2.77

2.0

2.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

360

0.53

2.74

1.0

1.28

1.96

u/ml

—

151

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

501

4237

0.86

2.72

2.6

3.0

48.43

52.67

mg/l

0.23

399

3432

(3008116) Ketones [Moles/volume] in Urine by Test strip

173

1.74

2.72

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1581

10678

1.09

2.72

4.5

3.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

349

0.52

2.71

1.0

0.40

1.09

u/ml

—

140

(3016750) Collection duration of Urine

633

0.65

2.71

2.1

2.0

494.24

500.88

min

0.14

438

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

868

0.70

2.70

1.1

91.23

573.73

iu/ml

0.71

139

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

885

0.70

2.69

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

479

0.59

2.69

1.1

1.4

3.89

3.44

—

107

(3008295) Osmolality of Serum or Plasma

174

986

1.29

2.69

1.3

275.18

274.66

mosm/kgh2o

0.09

120

713

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

746

0.68

2.68

1.1

1.2

5.00

4.34

u/ml

0.17

322

(3013707) Erythrocyte sedimentation rate by Westergren method

8765

62634

1.05

2.68

3.8

4.4

15.99

15.89

mm/h

0.20

7735

56614

(3047189) Immunofixation for 24 hour Urine

568

0.63

2.66

1.3

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

394

0.56

2.66

1.2

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2058

16092

0.93

2.65

2.2

2.7

0.81

mmol/l

0.05

1798

14699

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

856

0.70

2.64

1.1

252.57

293.25

u/ml

0.73

500

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

141

1351

0.76

2.62

1.5

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

956

0.72

2.61

2.1

1.9

—

0.96

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

456

0.59

2.60

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

758

0.68

2.60

1.2

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

134

0.33

2.59

2.3

2.5

114.83

1559.13

u/l

—

127

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

455

0.59

2.58

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

455

0.59

2.58

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

119

1163

0.75

2.56

1.5

1.6

3.29

3.55

mg/l

0.11

897

(3019225) pH of Specimen

1372

10892

0.91

2.55

4.2

4.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

452

0.60

2.52

1.1

—

(3036180) Methadone [Presence] in Urine

2.50

2.52

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

639

0.66

2.51

1.3

1.2

8.05

mmol/l

0.00

490

(40759836) Histone Ab [Presence] in Serum by Immunoblot

451

0.60

2.50

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

451

0.60

2.50

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4126

28930

1.06

2.50

2.3

2.5

60.08

63.42

u/l

0.53

3741

26462

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

394

1.45

2.48

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

2.46

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

230

0.44

2.46

2.6

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

339

2930

0.84

2.46

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

349

2158

1.19

2.45

1.3

61.98

61.06

mmol/l

0.18

281

1732

(3017446) Testosterone [Moles/volume] in Serum or Plasma

528

4410

0.87

2.45

2.0

9.90

10.40

nmol/l

0.59

427

3666

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

969

0.73

2.43

1.3

1.5

14.56

26.56

7.21

600

(3017732) Neutrophils [#/volume] in Blood

666

5476

0.88

2.43

3.4

3.3

6.34

5.71

e9/l

0.26

446

3887

(40768806) Pleura Pathology biopsy report

171

1581

0.79

2.43

1.4

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

186

1701

0.80

2.40

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

372

0.57

2.40

2.0

2.2

—

(3012544) pH of Venous blood

1644

11187

1.08

2.39

2.7

3.6

7.40

7.39

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

492

4120

0.87

2.38

2.6

3.0

3.10

3.43

ratio

0.14

294

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

192

1746

0.80

2.36

1.3

1.5

—

(3012441) Differential panel - Pleural fluid

172

1583

0.79

2.36

1.4

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

142

1336

0.78

2.34

1.3

1.4

6.41

mmol/l

0.00

120

1248

(3012565) Volume of 24 hour Urine

451

0.62

2.33

2.4

2.2

1581.20

1798.15

0.60

379

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

469

0.62

2.33

2.4

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

130

1236

0.77

2.32

3.3

3.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

177

1027

1.26

2.32

1.8

1.6

29.13

25.87

u/ml

0.43

214

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

574

0.66

2.30

1.0

1.1

1.45

4.23

u/ml

1.87

110

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

608

0.67

2.28

1.1

1.2

83.75

125.53

titre

—

114

(3010838) Calcium [Moles/time] in 24 hour Urine

149

1386

0.78

2.25

1.6

1.7

4.11

4.39

mmol/24h

0.50

108

1137

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1198

8073

1.09

2.21

2.2

2.3

36.37

38.07

u/l

0.15

978

6798

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

532

4406

0.88

2.21

2.1

2.6

0.37

0.35

u/ml

0.72

289

2518

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

612

0.68

2.21

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

278

0.53

2.20

1.5

1.4

8.58

10.23

ug/l

0.38

247

(3004451) EKG impression Narrative

646

0.69

2.19

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

114

0.32

2.18

1.4

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

891

0.74

2.17

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

313

0.56

2.14

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

154

1417

0.79

2.14

1.2

1.3

0.87

0.81

nmol/l

0.33

121

1157

(1001926) Buprenorphine [Presence] in Urine by Screen method

147

1.69

2.14

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

331

0.57

2.13

3.0

2.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

169

1537

0.80

2.12

1.3

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1965

15255

0.93

2.09

2.2

2.6

20.06

20.73

1.27

1432

12778

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

148

1.68

2.09

2.2

2.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

172

0.42

2.03

1.0

1.4

1.60

1.55

g/l

—

172

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

353

0.60

2.02

1.8

1026.93

1809.47

u/ml

1.54

340

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

600

0.69

2.01

1.5

4.49

7.16

u/l

0.71

477

(3051593) INR in Capillary blood by Coagulation assay

787

0.73

2.01

7.8

12.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

306

0.57

2.00

1.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

512

0.67

1.99

1.3

1.4

2.85

2.59

0.08

424

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2394

18433

0.94

1.98

1.6

1.7

1.78

1.59

mg/l

1.11

1839

14525

(42529582) MDA5 Ab [Presence] in Serum by Line blot

200

0.48

1.97

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

200

0.48

1.97

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

200

0.48

1.97

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

200

0.48

1.97

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

506

4169

0.88

1.97

3.4

4.3

24.97

24.91

mmol/l

0.15

422

3742

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

640

0.71

1.97

1.2

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

579

0.69

1.95

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

639

0.71

1.95

1.2

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

403

0.63

1.94

1.5

5.14

6.04

u/l

0.91

322

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

403

0.63

1.94

2.3

1.7

486.23

489.10

e6/l

0.01

346

(40758358) Immune stain study

0.00

1.93

0.0

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

663

0.72

1.93

3.0

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1285

10099

0.92

1.93

2.2

2.5

65.34

65.75

g/l

1.05

1052

8900

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.93

0.0

12.5

—

218.50

—

(3016038) Potassium [Moles/volume] in Urine

134

772

1.27

1.93

1.1

35.02

mmol/l

0.00

103

642

(3002385) Erythrocyte distribution width [Ratio]

9121

65519

1.04

1.92

24.4

22.6

15.02

15.66

26.52

8879

64128

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

311

0.59

1.91

1.5

1.7

4900.00

17006.02

e6/l

1.05

175

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

155

1403

0.81

1.90

1.3

459.13

399.69

u/l

0.22

137

1324

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

584

0.70

1.90

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

584

0.70

1.90

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

787

0.74

1.89

1.8

1.9

2.81

4.11

ug/l

1.08

713

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

828

5531

1.10

1.89

3.5

4.3

45.50

45.98

0.23

815

5464

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

163

1466

0.81

1.89

1.2

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

381

3183

0.87

1.86

2.8

3.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

148

1.63

1.85

2.2

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

867

0.76

1.85

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

120

1112

0.79

1.83

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

914

0.77

1.81

1.1

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

342

0.62

1.80

1.6

1.8

535.44

5089.11

e6/l

0.99

230

(3008536) Aspergillus sp Ab [Presence] in Serum

163

0.45

1.80

1.8

1.4

—

(3037121) Protein [Mass/volume] in Urine

439

3623

0.88

1.79

2.4

2.8

0.30

0.31

g/l

0.11

146

1397

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

1.75

0.0

2.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

310

2614

0.86

1.74

1.9

2.2

97.59

98.05

ug/min

0.01

156

1455

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

238

0.55

1.74

1.4

26.84

30.73

umol/l

1.55

228

(3009343) pH of Capillary blood

889

7059

0.92

1.74

2.9

3.8

7.42

0.83

125

934

(3048879) Bone marrow aspiration report

391

0.65

1.72

1.1

1.4

—

(3028433) Virus identified in Specimen by Culture

283

0.59

1.71

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

803

5385

1.10

1.71

2.2

2.5

1.14

1.12

0.37

797

5359

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

174

1049

1.22

1.71

2.6

2.3

2.50

2.28

u/field

0.19

341

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

240

1.46

1.71

1.3

1.5

17.62

16.80

pmol/l

0.44

184

(3034426) Prothrombin time (PT)

169

0.48

1.70

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

118

1.68

1.69

1.3

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

0.40

1.67

1.3

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4786

33991

1.04

1.65

4.8

5.9

6.84

4.94

ug/l

0.67

4041

29651

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.37

1.65

1.2

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

102

582

1.28

1.63

2.5

2.0

1.72

2.51

u/field

0.81

382

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

583

0.73

1.63

1.2

1.4

61.26

67.42

0.60

470

(3028308) Erythrocytes [#/volume] in Pleural fluid

191

1662

0.84

1.62

1.4

1.5

54214.64

66426.84

e6/l

0.28

118

981

(1002224) Polysomnography panel

132

1190

0.81

1.61

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

764

6083

0.91

1.61

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

241

0.58

1.61

1.3

55.72

37.73

u/l

0.70

193

(3023199) Leukocytes [#/volume] in Pleural fluid

210

1811

0.85

1.60

1.4

1.5

3849.05

2204.10

e6/l

0.69

154

1303

(3038071) Oxygen [Partial pressure] in Mixed venous blood

155

0.47

1.60

4.4

7.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

366

0.66

1.59

2.3

2.5

43.45

36.47

1.33

226

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

904

7141

0.92

1.59

2.9

3.8

5.17

5.16

kpa

0.17

807

6675

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.86

1.57

1.1

1.0

—

(3020650) Glucose [Presence] in Urine

173

0.51

1.56

2.9

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

266

0.60

1.56

1.1

1.03

1.11

ratio

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

191

0.54

1.54

5.0

8.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1023

6970

1.08

1.53

1.7

2.1

401.89

386.54

nmol/l

1.48

866

6261

(40768446) Kidney Pathology biopsy report

199

0.55

1.50

1.1

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

756

6000

0.92

1.50

1.5

1.6

1.60

1.57

g/l

0.35

589

5085

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.86

1.50

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

175

1.51

1.50

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

125

0.47

1.50

1.1

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.33

1.45

3.2

9.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

578

0.75

1.43

1.1

1.2

96.79

96.38

u/l

0.01

502

(3014051) Protein [Presence] in Urine by Test strip

309

2561

0.88

1.41

2.9

3.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

440

3570

0.90

1.40

4.9

5.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

101

920

0.80

1.40

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

234

1975

0.86

1.40

1.6

—

(3016879) Cocaine [Presence] in Urine

172

1.49

1.40

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

190

1.46

1.40

1.1

—

(3006462) Nitrate [Presence] in Urine

491

0.73

1.39

4.5

4.3

—

(3020393) Adenovirus Ag [Presence] in Stool

1.69

1.39

1.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

867

6816

0.93

1.38

3.0

3.7

1.95

2.06

mmol/l

0.40

611

5022

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

227

1.42

1.38

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

193

0.57

1.37

4.3

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

163

1413

0.84

1.37

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

179

1.47

1.37

1.2

—

(3019977) pH of Arterial blood

118

703

1.23

1.36

2.0

2.3

7.42

0.18

279

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

145

0.50

1.35

1.0

1.4

—

13.46

—

(1616796) Gas panel - Central venous blood

324

2668

0.89

1.35

3.2

3.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

125

1108

0.82

1.35

1.2

1.3

24.56

11.94

u/l

1.81

108

1012

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

781

5298

1.08

1.34

2.2

2.5

0.68

0.66

0.92

776

5274

(3028300) Cannabinoids [Presence] in Urine

180

1.46

1.34

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2104

16068

0.95

1.33

2.1

2.5

2.18

2.24

g/l

5.99

1829

14614

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

628

0.77

1.33

1.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

710

0.78

1.32

1.5

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

113

1009

0.82

1.32

1.3

1.5

13.99

13.58

u/l

0.30

105

961

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.45

1.31

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

618

0.77

1.30

1.5

1.8

165.46

188.66

pmol/l

1.60

556

(3036489) Thrombin time

350

2861

0.89

1.30

1.6

1.8

21.42

22.17

0.76

315

2603

(3008037) Lactate [Moles/volume] in Venous blood

378

3075

0.90

1.29

3.5

3.7

1.76

1.64

mmol/l

1.62

370

3014

(3035880) pH of Pleural fluid

837

0.80

1.29

1.1

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

294

2426

0.88

1.28

1.5

1.6

24167.64

14261.58

e6/l

1.45

203

1729

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1229

8490

1.06

1.28

2.7

3.6

90.18

99.69

ng/l

3.43

973

6980

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

231

1.39

1.28

1.1

1.03

1.14

u/l

1.18

117

(3006922) Hepatitis E virus Ab [Presence] in Serum

356

0.70

1.27

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

104

932

0.82

1.27

2.6

3.1

31.09

33.20

mg/l

0.08

700

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

607

4820

0.92

1.26

1.9

2.2

3.79

3.70

g/l

0.63

482

4209

(3006442) Creatine [Moles/volume] in Serum or Plasma

522

0.76

1.24

2.2

1.8

87.39

101.16

umol/l

1.59

522

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

168

0.57

1.23

1.3

—

2393057.14

—

(3024471) HLA-A [Type]

105

0.49

1.23

1.0

—

(3025577) Chromium [Mass/volume] in Blood

759

0.80

1.23

1.9

2.0

1.74

2.23

ug/l

1.15

635

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

213

0.62

1.22

1.0

—

2.41

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

269

2223

0.88

1.22

1.3

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

627

0.78

1.21

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1015

6985

1.07

1.20

2.6

3.2

127.80

125.25

g/l

3.47

989

6806

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

571

4534

0.92

1.20

1.8

2.2

10.44

10.29

g/l

0.28

442

3877

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

182

1542

0.86

1.19

2.2

34.85

28.08

mg/l

0.65

366

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.19

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

175

0.58

1.18

1.5

—

(3017569) Oxygen content in Arterial blood

600

0.78

1.18

2.5

2.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.45

1.18

1.3

1.2

—

876.22

—

(3024932) HLA-DR beta [Type]

0.45

1.18

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

292

1.33

1.17

1.6

1.8

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

1.17

0.0

1.1

—

15.52

—

(3044889) 12 lead EKG panel

8213

59201

1.03

1.16

4.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

164

0.58

1.14

1.0

1.3

113.50

114.03

—

140

(40761536) Microorganisms panel - Urine sediment

988

7669

0.94

1.14

4.8

4.7

—

(3045788) Cell count panel - Pleural fluid

162

1379

0.86

1.14

1.4

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1095

8470

0.94

1.13

2.2

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3806

27101

1.04

1.13

4.5

5.1

21.82

22.59

2.42

1897

15178

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

612

4828

0.92

1.12

1.9

2.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

120

0.55

1.10

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

613

4832

0.93

1.10

1.9

2.2

7.69

7.54

g/l

1.20

484

4218

(3038515) Glucose [Moles/volume] in Venous blood

365

2944

0.90

1.10

3.5

3.8

8.35

7.69

mmol/l

3.16

359

2885

(3028626) Oxygen [Partial pressure] in Capillary blood

340

2752

0.90

1.10

2.3

2.9

7.37

7.73

kpa

3.54

335

2681

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

734

5016

1.07

1.09

1.7

1.9

2.69

2.24

ug/l

0.27

567

4308

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

201

1.38

1.09

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

250

0.67

1.08

1.3

1.5

16.14

8.26

—

125

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.60

1.07

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

326

0.72

1.07

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

326

0.72

1.07

1.0

—

(3027944) Amphetamines [Presence] in Urine

171

1.41

1.07

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

136

847

1.18

1.05

1.3

265.45

384.00

titre

0.41

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

213

0.65

1.05

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

112

0.52

1.05

2.4

1.4

71.50

57.76

pmol/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

375

0.74

1.04

1.1

1.2

39.16

40.12

g/l

0.23

180

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

556

0.79

1.04

1.1

1.2

34.09

29.68

u/l

0.23

473

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.46

1.03

1.0

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

289

2349

0.90

1.03

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

113

979

0.84

1.02

1.3

1.4

194260.00

173700.90

e6/l

0.08

667

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

204

1.36

1.01

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

220

0.66

1.01

2.1

2.0

2.79

3.53

ug/l

1.14

(3014891) Appearance of Pleural fluid

242

1.33

1.01

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

306

1.29

1.01

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

268

1.31

1.00

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

157

0.61

0.99

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

279

0.71

0.99

1.1

130.59

149.59

mmol/24h

0.54

279

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.99

0.0

1.0

—

0.01

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

363

0.75

0.99

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.66

0.98

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.66

0.98

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.66

0.98

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

165

0.62

0.97

1.1

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.97

0.0

1.5

—

(3022689) Creatine [Moles/volume] in Urine

226

0.68

0.97

1.3

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

1.97

0.97

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

397

2663

1.09

0.96

2.1

2.3

126.78

125.09

g/l

0.65

319

1951

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

188

1.36

0.95

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.78

0.94

1.4

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

131

823

1.17

0.94

1.3

27.50

65.13

titre

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

818

5648

1.06

0.93

5.7

7.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

448

1.23

0.93

1.1

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

858

0.84

0.92

1.1

—

u/ml

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

208

1.34

0.92

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

172

1429

0.88

0.92

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

172

1429

0.88

0.92

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

406

0.77

0.90

6.1

5.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.09

0.89

1.2

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

289

0.73

0.88

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

1338

0.88

0.87

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

288

0.74

0.87

1.5

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

232

1879

0.90

0.82

2.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

530

0.81

0.82

4.8

4.7

68.78

141.82

u/ml

0.56

152

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

276

0.74

0.81

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

234

0.72

0.81

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

217

0.71

0.81

1.4

0.12

0.13

nmol/l

0.39

156

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.81

0.0

13.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.81

0.0

8.9

—

39.83

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.81

0.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

680

0.84

0.81

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.80

0.0

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

109

0.60

0.80

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

358

0.78

0.80

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

165

0.66

0.80

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

346

2744

0.92

0.80

1.3

1.4

259.19

260.50

ug/g

0.04

183

1689

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.79

0.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

224

0.72

0.78

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

120

0.61

0.78

4.4

7.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

274

0.75

0.78

1.0

1.1

9.35

11.72

iu/ml

—

(3024928) Oxygen saturation in Venous blood

318

2139

1.09

0.78

1.6

2.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4990

37133

0.98

0.77

3.0

3.3

2320.57

2066.10

ng/l

2.39

4190

32472

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

203

1.30

0.75

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

152

1.35

0.75

1.1

1.3

80.78

105.42

ug/l

0.50

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

230

1528

1.10

0.74

1.1

10.12

14.68

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.55

0.74

6.7

4.5

29.33

59.12

ug/min

—

(3009871) Measles virus Ab [Titer] in Serum

0.55

0.74

1.5

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

236

0.74

0.71

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

262

2088

0.92

0.70

1.2

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

244

0.75

0.70

1.4

12.73

15.48

g/l

0.76

193

(3034274) Bile acid [Moles/volume] in Serum --fasting

318

0.78

0.70

1.4

1.2

5.91

15.88

umol/l

2.13

215

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.93

0.70

1.4

1.5

501.80

339.93

nmol/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

572

4429

0.94

0.70

1.9

2.3

3.04

3.01

g/l

0.20

443

3816

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

168

0.70

0.69

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.65

0.67

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.83

0.67

1.2

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.83

0.67

1.2

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

444

0.82

0.66

1.0

1.1

1.90

11.39

nmol/l

—

103

(3027273) Bicarbonate [Moles/volume] in Venous blood

861

6026

1.05

0.66

2.8

3.4

25.36

25.13

mmol/l

1.19

821

5856

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

166

0.70

0.66

1.7

9.48

10.00

ug/l

0.21

166

(3036071) Salmonella sp Ab [Titer] in Serum

140

0.68

0.65

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

199

0.73

0.65

1.3

66.60

206.20

nmol/24h

1.50

199

(3044007) Cell count panel - Peritoneal fluid

273

0.78

0.64

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.60

0.64

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

281

0.78

0.64

1.4

2.0

0.32

0.79

mmol/l

0.19

262

(3020961) Endomysium IgA Ab [Titer] in Serum

335

2630

0.93

0.64

1.1

469.44

225.46

titre

—

(3033799) Differential panel - Peritoneal fluid

305

0.79

0.64

1.6

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

206

0.75

0.63

1.0

1.1

0.58

0.66

umol/24h

0.41

(3018291) Platelet Ab [Presence] in Serum

0.00

0.61

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

101

0.65

0.61

1.2

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

0.65

0.61

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

112

0.65

0.61

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.61

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.61

0.0

1.1

—

8.21

—

(36303858) Crystals [Presence] in Urine

0.00

0.61

0.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.61

0.0

6.9

—

(37021550) Renin [Units/volume] in Plasma --upright

188

0.74

0.60

1.3

38.60

72.08

mu/l

1.16

130

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

525

0.85

0.60

4.6

3.1

—

(3051101) Glucose [Moles/volume] in Cord blood

245

0.78

0.59

4.8

5.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.55

0.59

1.8

1.3

—

(3049717) Cytology report of Urine Cyto stain

656

5029

0.95

0.59

2.7

2.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

236

0.77

0.58

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

389

0.83

0.58

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

243

0.78

0.56

1.2

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.44

0.56

2.0

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

489

1.15

0.56

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

118

0.68

0.56

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

218

0.77

0.56

1.3

26.75

54.73

g/l

0.57

180

(3011335) Digoxin [Mass/volume] in Serum or Plasma

160

0.73

0.55

2.6

2.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

408

1.17

0.55

1.2

1.07

1.18

nmol/l

0.36

303

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.53

0.55

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

394

0.84

0.55

1.4

54.71

35.64

iu/l

2.09

330

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

386

0.83

0.55

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

209

0.77

0.54

1.2

1.1

245.00

272.46

pmol/l

0.21

142

(3000991) Gas panel - Venous blood

1202

9077

0.97

0.54

4.5

6.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

893

6780

0.96

0.54

5.3

7.2

92.84

93.66

2.50

887

6751

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

385

0.84

0.53

1.1

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1262

8953

1.03

0.53

3.1

3.9

1.23

mmol/l

0.87

1003

7720

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

142

0.72

0.53

1.1

1.2

13.14

17.32

u/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

150

0.73

0.53

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.43

0.52

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

587

4103

1.05

0.52

2.6

3.1

4.26

4.28

pmol/l

0.23

488

3477

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.39

0.51

11.2

11.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

412

3180

0.95

0.51

1.9

2.3

0.00

g/l

-0.00

343

2875

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

144

1155

0.91

0.50

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

170

1353

0.92

0.50

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

106

0.69

0.49

1.2

3.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.36

0.49

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

164

0.76

0.48

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

151

1.26

0.48

1.2

1.1

1526.62

1747.06

miu/ml

0.39

151

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

513

0.87

0.48

1.5

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6172

44690

1.02

0.48

2.9

3.1

50.61

57.42

u/l

5.95

5382

39789

(3006576) Bicarbonate [Moles/volume] in Blood

379

0.85

0.47

3.3

6.3

24.59

24.71

mmol/l

0.09

342

(3041918) Cholesterol [Moles/volume] in Pleural fluid

251

0.82

0.45

1.1

1.2

1.51

1.47

mmol/l

0.06

152

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

116

934

0.91

0.45

1.3

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

173

1170

1.08

0.45

3.2

3.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

120

1.28

0.45

4.4

5.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.44

0.45

1.6

1.3

1.33

1.03

u/field

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

180

1419

0.93

0.44

1.3

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

308

1.16

0.44

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

368

0.85

0.43

5.9

5.3

60.91

71.99

1.25

286

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.43

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

177

0.79

0.43

1.1

—

(3024263) Appearance of Synovial fluid

529

1.12

0.43

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1231

8770

1.03

0.43

1.6

2.0

0.20

g/l

0.09

1063

8024

(3027315) Oxygen [Partial pressure] in Blood

338

2606

0.95

0.43

3.7

4.4

7.83

8.28

kpa

7.30

324

2527

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.59

0.43

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.42

0.0

3.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.42

0.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

1.08

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.42

0.0

8.3

—

55.60

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

423

3239

0.95

0.41

1.9

2.3

0.00

g/l

0.21

344

2887

(3029075) Extractable nuclear Ab panel - Serum

184

0.79

0.41

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

319

0.85

0.41

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

0.20

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.01

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3021901) Oxygen saturation in Capillary blood

307

2369

0.95

0.41

2.3

2.9

—

(3015183) Erythrocyte sedimentation rate

143

0.77

0.41

1.1

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

183

0.80

0.40

1.3

1.4

85.09

75.34

0.71

155

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.67

0.40

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

442

0.88

0.39

1.3

484.50

249.16

ug/l

0.23

244

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

259

2005

0.94

0.39

1.6

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

454

3464

0.96

0.39

1.8

2.2

0.02

0.05

g/l

2.00

373

3096

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3257

24155

0.98

0.38

2.5

3.0

34.61

37.71

u/l

1.26

2983

22539

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

141

0.78

0.37

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

0.78

0.36

1.0

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

243

0.84

0.35

1.6

1.5

0.45

0.39

ug/l

0.18

128

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

235

0.84

0.35

1.2

1.3

2.68

1060.50

u/l

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

329

1.13

0.35

1.2

1.4

76.35

61.62

3.81

285

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

650

1.09

0.35

1.2

1.11

1.48

nmol/l

4.80

588

(40757494) Bilirubin.total [Moles/volume] in Blood

566

1.10

0.34

1.7

2.0

19.60

24.62

umol/l

—

(3013290) Carbon dioxide [Partial pressure] in Blood

339

2592

0.96

0.34

3.7

4.4

5.03

5.01

kpa

0.19

326

2513

(3012501) Base excess in Blood by calculation

339

2590

0.96

0.33

3.7

4.4

2.61

2.82

mmol/l

0.61

233

1786

(3011648) Oxygen content in Venous blood

650

0.91

0.33

1.2

1.6

10.21

10.29

0.06

650

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.66

0.33

3.7

4.7

—

(3051651) Icteric interference index of Serum or Plasma

617

1.09

0.33

3.2

3.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

409

3110

0.96

0.33

2.5

3.1

24.90

24.98

mmol/l

0.15

397

3041

(3000285) Sodium [Moles/volume] in Blood

167

1.18

0.32

1.4

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.26

0.30

1.1

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

134

917

1.07

0.30

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

112

0.78

0.30

1.0

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

134

918

1.07

0.30

1.3

—

(36660697) Celiac disease serology panel - Serum

679

5103

0.97

0.29

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

315

0.88

0.29

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

284

0.88

0.29

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

605

0.92

0.28

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

229

0.86

0.28

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

390

2755

1.04

0.28

1.4

1.5

—

(40758558) Short blood count panel - Blood

2985

21595

1.01

0.27

5.1

6.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.25

0.27

1.0

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

3136

22698

1.01

0.27

3.5

4.0

80.06

81.76

3.07

3036

22161

(3038177) Helicobacter pylori Ab [Presence] in Serum

109

853

0.93

0.27

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

954

6833

1.02

0.27

5.0

7.0

1.44

1.33

4.08

947

6769

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

189

0.85

0.27

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.69

0.26

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.69

0.26

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

212

1.14

0.26

1.1

1.2

111.55

136.11

nmol/l

0.48

156

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.25

0.25

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

203

0.86

0.25

1.4

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.18

0.24

1.1

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2328

17231

0.99

0.24

2.1

2.5

10.95

11.51

umol/l

3.48

2011

15753

(3024869) Neuronal Ab [Presence] in Serum

187

0.86

0.24

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.70

0.24

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.31

0.23

1.8

1.6

—

(3001729) Color of Synovial fluid

111

1.19

0.23

1.5

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

536

4021

0.97

0.23

1.9

2.4

1.37

1.20

g/l

0.34

402

3316

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

411

1.09

0.22

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

243

1.11

0.22

1.4

1.3

20.65

30.56

1.25

154

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

285

1.10

0.22

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

804

5998

0.98

0.22

4.4

5.8

24.72

24.84

mmol/l

0.36

792

5920

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

6.7

—

8.88

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.22

0.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.22

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.22

0.0

2.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.22

0.0

2.6

—

2.77

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

391

1.09

0.21

2.6

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

213

1621

0.96

0.21

1.5

1.6

3.06

4.42

iu/l

2.32

455

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

2.33

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1530

11043

1.02

0.21

1.7

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

731

0.94

0.21

1.0

1.1

—

15.58

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.76

0.21

1.4

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

2.29

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

199

0.88

0.20

1.5

1.4

127.90

127.55

ng/l

0.01

199

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

656

1.06

0.20

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

127

1.15

0.19

1.4

1.6

40.55

47.00

umol/l

0.57

127

(3029396) Erythrocyte agglutination [Presence] in Blood

1.16

0.19

1.5

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

627

4497

1.02

0.19

1.9

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

946

6813

1.02

0.18

5.0

7.1

0.71

0.67

2.88

936

6751

(40767503) Oxygen content in Capillary blood by calculation

330

2481

0.97

0.18

2.4

2.6

16.18

15.59

1.80

153

1339

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

310

1.09

0.18

1.6

1.7

11.10

13.95

nmol/l

2.12

281

(3023511) Choriogonadotropin [Units/volume] in Urine

1.19

0.18

1.6

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

431

1.07

0.18

3.9

2.9

221.06

220.62

u/l

0.02

426

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

135

1.14

0.18

1.3

1.7

1.66

1.17

ug/l

0.41

126

(3025941) Bacteria identified in Stool by Culture

592

4253

1.02

0.16

1.3

—

(3017704) Immunofixation for Urine

683

1.05

0.16

1.5

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.10

0.16

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

557

0.95

0.16

1.2

217.30

179.31

miu/ml

—

109

(3025549) Creatine [Moles/time] in 24 hour Urine

1.16

0.15

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

194

0.90

0.14

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

181

1366

0.97

0.14

5.0

5.8

12.97

12.65

mg/l

0.40

154

1217

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.18

0.14

1.0

1.1

0.83

1.12

u/field

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

522

3884

0.98

0.14

1.2

1.3

48.46

58.67

au/ml

0.42

211

(3022493) Free Hemoglobin [Mass/volume] in Plasma

427

0.94

0.14

1.1

2.6

63.41

65.87

mg/l

0.12

283

(3052851) Hemolysis interference index of Serum or Plasma

443

3299

0.98

0.13

3.3

3.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

214

0.92

0.11

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

439

1.05

0.11

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

0.88

0.11

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

213

0.93

0.10

1.3

20.76

23.11

0.13

163

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.10

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

671

4854

1.01

0.10

2.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.08

0.09

1.2

1.1

178.40

277.57

nmol/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

174

0.92

0.09

1.2

38.67

249.51

u/l

0.58

116

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

361

2679

0.99

0.09

1.1

0.99

1.20

u/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.07

0.08

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1364

9913

1.01

0.08

2.2

2.5

9.76

10.01

umol/l

0.13

1104

8588

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11371

83089

1.00

0.08

9.5

11.7

22.34

23.27

u/l

1.80

10592

78931

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

602

4360

1.01

0.08

2.2

2.4

37.49

23.91

au/ml

0.67

176

(3029634) Reagin Ab [Titer] in Serum by VDRL

581

1.03

0.08

1.4

1.5

—

2.75

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

661

1.03

0.08

2.3

1.8

298.01

323.83

mu/l

0.33

600

(3036525) Urea [Moles/time] in 24 hour Urine

0.83

0.08

2.0

3.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.08

0.07

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.07

1.0

1.1

1.78

1.68

umol/24h

0.23

(3001964) Herpes simplex virus Ag [Presence] in Specimen

224

0.95

0.07

1.4

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6647

48540

1.00

0.06

4.0

5.8

12.67

12.45

umol/l

0.53

6076

45877

(3044941) Cell count panel - Synovial fluid

214

1542

1.02

0.06

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

555

1.03

0.06

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

555

1.03

0.06

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

0.87

0.06

1.4

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

502

3705

0.99

0.06

1.8

2.2

36.30

36.75

g/l

0.81

368

3077

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

339

1.04

0.06

1.3

1.4

15.67

20.74

0.78

278

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

116

1.07

0.05

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

165

1190

1.01

0.05

1.5

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

109

811

0.98

0.04

1.1

1.2

—

(4212803) Bone marrow aspirate examination

117

0.94

0.04

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

128

949

0.99

0.03

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1458

10694

1.00

0.03

2.2

2.4

64.60

67.17

e9/l

2.01

1083

8184

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

151

1094

1.01

0.02

2.6

2.9

—

(3010421) pH of Blood

404

2942

1.00

0.02

3.5

4.2

7.42

0.89

346

2677

(3042010) Triglyceride [Moles/volume] in Pleural fluid

184

1.03

0.02

1.2

0.73

1.71

mmol/l

0.98

110

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

167

0.96

0.02

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

127

1.04

0.01

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.05

0.00

1.6

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

458

0.99

0.00

1.3

3.88

3.29

mmol/l

0.57

420

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.03

0.00

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

110

1.00

0.00

2.2

1.7

59.00

1921.23

e6/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

0.00

1.2

11.50

11.99

u/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.99

0.00

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

218

1.01

0.00

1.1

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

234

1.00

0.00

1.6

94.70

115.16

ug/l

0.46

196

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

121

1.03

0.00

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

259

0.99

0.00

2.7

2.5

7.20

7.52

mmol/l

0.38

175

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

0.99

0.00

1.3

1.1

—

(3020491) Glucose [Moles/volume] in Blood

643

1.00

0.00

1.8

2.3

7.29

7.32

mmol/l

0.05

429

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.05

0.00

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.96

0.00

1.4

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

5.67

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

31.00

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.94

-0.00

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.90

-0.00

2.0

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.88

-0.00

1.2

1.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

70.20

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.98

-0.00

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.6

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.02

-0.00

1.7

1.6

26.77

16.46

umol/l

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.91

-0.00

1.3

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.00

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.97

-0.00

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

3.44

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.97

-0.00

1.1

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ALZHEIMER and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_ALZHEIMER	2.419 [2.2, 2.66]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 74328 out of 110920 females with G6_ALZHEIMER died.

Males

Parameter	HR [95% CI]	p-value
G6_ALZHEIMER	2.756 [2.43, 3.13]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 42782 out of 61190 males with G6_ALZHEIMER died.

Mortality risk

Mortality risk for people of age

years, who have G6_ALZHEIMER.

N-year risk	Females	Males
1	0.184%	0.451%
5	1.156%	2.751%
10	2.546%	6.244%
15	4.559%	11.313%
20	8.12%	18.563%

Relationships between endpoints

↥

Index endpoint: G6_ALZHEIMER – Alzheimer disease

GWS hits: 30

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alzheimer disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints